{"id":892,"date":"2015-05-22T22:25:13","date_gmt":"2015-05-23T02:25:13","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/6-9-iv-main-and-mini-bag-medications\/"},"modified":"2022-06-08T14:31:29","modified_gmt":"2022-06-08T18:31:29","slug":"7-6-intravenous-medications-by-direct-iv-formerly-iv-push","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-6-intravenous-medications-by-direct-iv-formerly-iv-push\/","title":{"raw":"7.6 Intravenous Medications by Direct IV  (Formerly IV Push)","rendered":"7.6 Intravenous Medications by Direct IV  (Formerly IV Push)"},"content":{"raw":"In the past, IV medications given as described above were referred to as IV bolus or IV push medications. It is recommended that these terms NOT be used, as they can be mistakenly interpreted as meaning the drugs are to be pushed quickly, in less than a minute (ISMP, 2003). To administer IV medications safely and effectively, nurses must follow all\u00a0 agency policies and use\u00a0PDTM guidelines to determine which\u00a0medications can be given intravenously and any specific instructions about administration (Alberta Health Services, 2009).\r\n\r\nIntravenous (IV)\u00a0is a route for administering concentrated medications (diluted or undiluted) directly into the vein. Depending on the medication and the purpose, meds given IV may be through continuous infusions, mini-bags, or more quickly by what is referred to as direct IV.\u00a0 The IV direct route refers to the administration of a small volume of fluid \/ medication (max. 20 ml) pushed manually into the patient using a syringe Leur locked to a needleless port. Medications given by direct IV are usually administered intermittently to treat emergent concerns. Medications administered by direct IV route are given very slowly over at least one minute (Perry et al., 2014). The nurse must consult drug monographs and \/ or Parenteral Drug Therapy Manual (PDTM) for specifics about each medication. Administering a medication intravenously eliminates the process of drug first pass by depositing the medication directly into the blood. This results in the immediate elevation of serum drug levels and high drug concentrations in vital organs, such as the heart, brain and kidneys. Both therapeutic and adverse effects can occur quickly with IV direct administration (Alberta Health Services, 2009).\u00a0 <span style=\"text-indent: 1em; font-size: 14pt;\">\u00a0<\/span>\r\n\r\nThere are many advantages and disadvantages to administering medications via the intravenous injection method\u2014see\u00a0Table 7.7.\r\n<table style=\"height: 662px;\">\r\n<tbody>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000; text-align: left;\" colspan=\"4\">\r\n<h3 style=\"text-align: center;\"><a id=\"table7.7\"><\/a>Table 7.7 Advantages\u00a0and Disadvantages of Intravenous Medications<\/h3>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">Advantages<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">Disadvantages<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Intravenous medications can deliver an immediate, fast-acting therapeutic effect, which is important in emergent situations such as cardiac arrest or narcotic overdose.\u00a0They are useful to manage pain and nausea by quickly achieving therapeutic levels, and they are\u00a0more consistently and completely absorbed compared with medications given by other routes of injection.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Once an intravenous medication is delivered, it cannot be retrieved.\u00a0When giving IV medications, there is very little opportunity to stop an injection if an adverse reaction or error occurs. IV medications, if given too quickly or incorrectly, can cause significant harm or death.<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Doses of short-acting medication can be titrated according to patient responses to drug therapy. Medication can be prepared quickly, and given over a shorter period of time compared to the IV piggyback route.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Any toxic or adverse reaction will occur immediately and may be exacerbated by a rapidly injected medication.<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Minimal dilution is required for some medications, which is desirable for patient's own fluid restrictions.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Extravasation of certain medications into surrounding tissues can cause tissue damage, nerve damage, and scarring.<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">There is minimal or no discomfort for the patient in comparison to SC and IM injections.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Not all medications can be given via the direct IV route.<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">They provide an alternative\u00a0to the oral route for drugs that may not be absorbed by the GI tract, and they are ideal for patients with GI dysfunction or malabsorption, and patients who are NPO (nothing by mouth) or unconscious.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">There is a high risk for infusion reactions,\u00a0mild to severe, because most IV medications peak rapidly (i.e., they have a quick onset of effect).\u00a0A hypersensitivity reaction can occur immediately or be delayed, and requires supportive measures.<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">IV direct route provides a more accurate dose of medication because none is left in the intravenous tubing.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Route for administering medications may damage surrounding tissues. There is an increased risk of phlebitis with highly concentrated medication, especially with small peripheral veins or a short venous access device.<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"4\">Data source:\u00a0Albert Health Services, 2009; Lynn, 2011;\u00a0Perry et al., 2018<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\nIntravenous medications are always prepared using the SEVEN rights and THREE checks as per agency policy. Because of the high risk associated with direct intravenous medications, additional guidelines are required. A PDTM or drug monograph provides additional information to help the nurse make decisions about administering IV medications. Some medications can be given either IV direct or piggyback, in which case the nurse must use their knowledge about the patient to determine which of these is preferred. Some medications may only be given in\u00a0 large-volume IV solutions; some medications have to be diluted; some medications have to be administered over specific time frames (i.e., over 1 or 2 minutes). In addition, information regarding indications, contraindications, dosage (age dependent), administration\/dilution guidelines, adverse effects, clinical indications (e.g., specialized monitoring required, must be on an IV pump), compatibility and incompatibility in relation to reconstitution and primary IV solution is specified (Alberta Health Services, 2009).\r\n\r\nThe Institute for Safe Medication Practices (ISMP) (2014) has created a list of high-alert medications that bear the heightened risk of significant harm when they are used in error. Special safeguards for these medications can be found in the PDTM. It is vital to understand which medications are considered high risk prior to administration. A link to the list of high-risk medications can be found under S<a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-9-summary\/\">uggested Online Resources<\/a> at the end of this chapter.\u00a0Review the steps shown in Table 7.8 to prepare a medication by direct IV route.\u00a0The PDTM must be consulted every time an IV medication is given, as memory-based errors are common (World Health Organization, 2012).\r\n<table>\r\n<tbody>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000; text-align: left;\" colspan=\"4\">\r\n<h3 style=\"text-align: center;\"><a id=\"table7.8\"><\/a>Table 7.8 Preparation Questions for Intravenous Medications<\/h3>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000; text-align: left;\" colspan=\"4\">\r\n<h5>Safety considerations:<\/h5>\r\n<ul>\r\n \t<li>Be diligent and follow all policies related to medication calculations, preparation, and thorough assessment of patient status before and after an injection. Medication errors are the most common preventable errors in health care.<\/li>\r\n \t<li>Use a blunt filter needle or blunt needle when preparing injections. Never use a needle when injecting IV medication. Always use a needleless system.<\/li>\r\n \t<li>After preparing the medication, always label the medication syringe with two patient identifiers, date, time, medication, dose, and your initials. Never leave the syringe unattended.<\/li>\r\n \t<li>Correctly identify the VAD, and use agency flushing and locking protocols for correct administration.<\/li>\r\n \t<li>Always administer the post-saline lock flush at the SAME RATE as the IV medication.<\/li>\r\n \t<li>Always assess the patient's symptoms and need for IV medication prior to administration.<\/li>\r\n \t<li>Always assess the patient's understanding of the medication.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">Principle<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">Additional Information<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Verify qualifications for administration.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\r\n<p style=\"text-align: left;\">Are you qualified to give this medication? What supervision is required? What resources must you consult?<\/p>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Review route of administration and IV site.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\r\n<p style=\"text-align: left;\">Can this medication be given by the IV route? Is the route of administration (needle insertion site) free from redness, swelling, and discomfort?<\/p>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Review preparation and how to administer the medication.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">How is this medication given by the IV route (diluted or undiluted)? Describe the safest way to prepare the medication. Consider the selection of medication. Always use less-concentrated solutions whenever possible. Does the medication require dilution? If diluting the medication, ALWAYS discard (that is, waste) the unused portion before going to the bedside.\r\n<ul>\r\n \t<li>Preparation and supplies:\u00a0is a pre-flush required?<\/li>\r\n \t<li>Patient identification:\u00a0any allergies?<\/li>\r\n \t<li>Administration rate:\u00a0what is the correct rate of administration (over 1 minute, 5 minutes)?<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Identify when a medication starts to work.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">What is the onset, peak, and duration of the medication?<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Assess dose and range (e.g., 5 to\u00a010 mg).<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Is the ordered dose safe? When did the patient last receive this medication? What was the effect of the medication on the patient?<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Understand the therapeutic effect.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">What is the expected therapeutic effect of the medication? What assessment is necessary to determine if the medication is correct for the patient?<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Know adverse effects.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">What are the potential adverse effects of the medications? How would you manage these adverse effects? Is there an antidote?<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Know potential incompatibilities.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Are there any potential incompatibilities with existing IV solutions? How would you manage these issues? Is a secondary medication currently running? Are there additives to the IV solution?<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Know how to complete the\u00a0procedure.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">How do you complete this procedure? Is a post-saline lock flush required?<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Document procedure.<\/td>\r\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">How and where do you chart this medication: pain assessment sheet, MAR, etc.?<\/td>\r\n<\/tr>\r\n<tr style=\"border: 1px solid #000000;\">\r\n<td style=\"border: 1px solid #000000;\" colspan=\"4\">Data source: BCIT, 2015; Berman &amp; Snyder, 2016; Clayton et al., 2010; WHO, 2012<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\nBefore giving an intravenous medication, always assess the IV insertion site for patency and for signs of infiltration or phlebitis. Start a new IV site if current site is red, swollen, or painful when flushing. Intravenous medications by direct IV route can be given three ways:\r\n<ul>\r\n \t<li>Through an IV that is capped \/ locked.<\/li>\r\n \t<li>Through an IV that has an infusion running and the medication is compatible with the IV solution.<\/li>\r\n \t<li>Through an IV that has an infusion running and the medication is incompatible with the IV solution.<\/li>\r\n<\/ul>\r\nChecklist 60 reviews the steps to administer a medication IV direct into a locked \/ capped IV. Review the preparation questions for intravenous medication in <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-6-intravenous-medications-by-direct-iv-formerly-iv-push\/\">Table 7.8 <\/a>prior to administering medication.\r\n<table style=\"border-color: #000000; height: 2977px; width: 100%;\" border=\"1px solid rgb(0, 0, 0)\">\r\n<tbody>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 867.8px; text-align: center; height: 116px;\" colspan=\"4\">\r\n<h3 style=\"text-align: center;\"><a id=\"checklist60\"><\/a>Checklist 60: Administering Medications IV Direct into a Locked \/ Capped IV\u00a0(PVAD Short, Midline, PICC, Percutaneous Non-Hemodialysis CVC)<\/h3>\r\n<h5 style=\"text-align: center;\"><em><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your agency policy regarding this specific skill.<\/span><\/em><\/h5>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 867.8px; height: 375px;\" colspan=\"4\">\r\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\r\n<ul>\r\n \t<li>Review the advantages and disadvantages of IV medications.<\/li>\r\n \t<li>Be able to answer the preparation questions for intravenous medication in Table 7.9 before administering the medication.<\/li>\r\n \t<li>If the medication has been diluted and there is wastage, always discard unused diluted portion of the prepared IV medication before going to the bedside.<\/li>\r\n \t<li>Always label the IV syringe with two patient identifiers, date, time, medication, dose, and your initials. Once the medication is prepared, never leave it unattended.<\/li>\r\n \t<li>Never administer an IV medication into an IV line that isn't patent.<\/li>\r\n \t<li>Central venous catheters (percutaneous non-hemodialysis lines, PICC lines) and midline catheters may require special pre- and post-flushing procedures and specialized training.<\/li>\r\n \t<li>Always follow agency policies and guidelines when preparing and administering medications.<\/li>\r\n \t<li>CVCs require at minimum a 10 ml syringe to decrease risk of catheter fracture.<\/li>\r\n \t<li>If using prefilled saline syringes, remove air prior.<\/li>\r\n \t<li>You will need a clock . watch \/ timer to time the rate of administration.<\/li>\r\n \t<li>Perform hand hygiene before preparing medications.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; text-align: center; height: 65px;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">Steps<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; text-align: center; height: 65px;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 352px;\" colspan=\"2\">1. Prepare one medication for one patient at the correct time as per agency policy. Review the physician's order, PDTM, and MAR for the correct order and guidelines. Math calculations may be required to determine the correct dose to prepare the medication.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 352px;\" colspan=\"2\">Always apply the SEVEN rights and THREE checks of medication administration.\r\n\r\nReview the agency policy if a medication is a stat, given for the first time, a loading dose, or a one-time dose.\r\n\r\nSome agencies require that high-alert medications be double-checked by a second health care provider. Always follow agency policies. For a list of high-alert medications, see <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-9-summary\/\">Suggested Online Resources.<\/a>\r\n\r\nAfter preparing the medication, always label the medication syringe with two patient identifiers (name &amp; date of birth), date, time, medication, dose (ie. 2 mg), and your initials. Never leave the medication syringe unattended.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 16px;\" colspan=\"2\">2. Create privacy if possible.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 16px;\" colspan=\"2\">This provides comfort to patient.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 242px;\" colspan=\"2\">3. Confirm patient ID using two patient identifiers (e.g., name and date of birth) AND compare the MAR with the patient's wristband to confirm patient ID.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 242px;\" colspan=\"2\">This ensures you have the correct patient and complies with agency standard for patient identification.\r\n\r\n[caption id=\"attachment_6143\" align=\"aligncenter\" width=\"152\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-430.jpg\"><img class=\"wp-image-6143\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Book-pictures-2015-430-300x231.jpg\" alt=\"Compare MAR with patient name band\" width=\"152\" height=\"117\" \/><\/a> Compare MAR with patient wristband[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 34px;\" colspan=\"2\">4. Check allergy band for any allergies, and ask patient about type and severity of reaction.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 34px;\" colspan=\"2\">This ensures allergy status is correct on the MAR and on patient's allergy band.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 88px;\" colspan=\"2\">5. Discuss purpose, action, and possible side effects of the medication. Provide patient an opportunity to ask questions. Encourage patient to report discomfort at the IV site (pain, swelling, or burning).<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 88px;\" colspan=\"2\">Keeping the patient informed of what is being administered helps decrease anxiety.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 79px;\" colspan=\"2\">6. Perform hand hygiene<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 79px;\" colspan=\"2\">Hand hygiene prevents the transmission of microorganisms.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 222px;\" colspan=\"2\">7. Assess IV insertion site for complications. See <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-5-iv-administration-equipment\/\">Checklist 65<\/a>.\r\n\r\n&nbsp;\r\n\r\nClean access port \/ needleless cap using alcohol and friction for 15 seconds. Allow to dry.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 222px;\" colspan=\"2\">Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective. Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.\r\n\r\n[caption id=\"attachment_1950\" align=\"aligncenter\" width=\"232\"]<img class=\" wp-image-1950\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-014-300x194.jpg\" alt=\"\" width=\"232\" height=\"150\" \/> Figure 7.29 Clean access port[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 326px;\" colspan=\"2\">8.\u00a0 Luer lock 10 ml saline filled syringe onto needleless cap. Release clamp on extension tubing if present.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 326px;\" colspan=\"2\">10 ml syringes for flushing reduces risk of fracturing the IV cannula.\r\n\r\n[caption id=\"attachment_1943\" align=\"alignleft\" width=\"235\"]<img class=\" wp-image-1943\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-002-300x167.jpg\" alt=\"\" width=\"235\" height=\"131\" \/> Figure 7.30 Luer lock saline syringe onto needleless cap[\/caption]\r\n\r\n[caption id=\"attachment_6188\" align=\"alignright\" width=\"199\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0928.jpg\"><img class=\"wp-image-6188\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/DSC_0928-300x199.jpg\" alt=\"Release clamp\" width=\"199\" height=\"132\" \/><\/a> Release clamp if present[\/caption]\r\n\r\n&nbsp;\r\n\r\n&nbsp;\r\n\r\n&nbsp;\r\n\r\n&nbsp;\r\n\r\n&nbsp;\r\n\r\n&nbsp;\r\n\r\nRefer to agency guidelines for VAD<a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\"> flushing &amp; locking protocols.<\/a><\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 239px;\" colspan=\"2\">9. Verify <strong>patency<\/strong> of the line.\r\n\r\n&nbsp;\r\n\r\n<strong>PVAD short:<\/strong>\r\n<ul>\r\n \t<li>You can aspirate...or not.<\/li>\r\n \t<li>Forward flush normal saline (follow agency flushing protocol\u2014usually 2 to 5 ml turbulent flush).<\/li>\r\n<\/ul>\r\n<strong>Midline, CVC (PICC \/ percutaneous non-hemodialysis line):<\/strong>\r\n<ul>\r\n \t<li>Aspirate for blood return. When blood flashback present in tubing forward flush using turbulent technique (follow agency flushing protocol\u2014usually 10 ml 0.9%NS).<\/li>\r\n \t<li>Do not force if resistance is felt.<\/li>\r\n<\/ul>\r\nRemove syringe.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 239px;\" colspan=\"2\">PVAD short: if swelling, pain, or redness exists, remove IV cannula and reestablish new IV site. Tenderness is the first sign of phlebitis.\r\n\r\nAspirating on a PVAD short often does not reveal blood flashback despite the site being patent. Assess for patency of PVAD short during the flush by assessing for resistance, pain, and leaking. If you suspect the line is not patent, STOP. DO NOT forward flush. Remove the PVAD short and reestablish a new one.\r\n\r\nTurbulent flush is a stop start vigorous motion intended to clean the inside lumen of the VAD.\r\n\r\n&nbsp;\r\n\r\nAspirating on a PICC, midline, and percutaneous non-hemodialysis CVC should reveal blood flashback. If you suspect the line is not patent, or partially occluded, follow agency guidelines (this usually involves trouble shooting and \/ or consulting the IV team \/ PICC nurse for declotting).\r\n\r\nIf possible, aspirate only until flashback of blood is into the catheter. Flashback into syringe creates more risk for occlusion if not flushed correctly.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 257px;\" colspan=\"2\">10. Clean access port with alcohol and friction for 15 seconds.\r\n\r\n&nbsp;\r\n\r\nLuer lock medication syringe\u00a0 to needleless cap.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 257px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.\r\n\r\nUsing a needleless system prevents needle-stick injuries.\r\n\r\nUse 10 ml syringe (minimum) to reduce risk of catheter fracture.\r\n\r\n[caption id=\"attachment_9403\" align=\"aligncenter\" width=\"200\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/11\/IMG_6604.jpg\"><img class=\"wp-image-880\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6604-300x225.jpg\" alt=\"IMG_6604\" width=\"200\" height=\"150\" \/><\/a> Luer lock medication filled syringe to the needleless cap[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 297px;\" colspan=\"2\">11.\u00a0Use a timer \/ watch \/ clock to inject medication at the correct rate according to agency policy. Administer the medication slowly and steadily. Attempt to have half of the syringe emptied in half of the recommended infusion time.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 297px;\" colspan=\"2\">Timing of the administration promotes safer medication administration. Rapid injection of IV medications can have serious consequences for the patient.\r\n\r\n[caption id=\"attachment_9404\" align=\"aligncenter\" width=\"200\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/11\/IMG_6607.jpg\"><img class=\"wp-image-881\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6607-300x225.jpg\" alt=\"Inject medication into saline lock\" width=\"200\" height=\"150\" \/><\/a> Inject medication into the venous access device[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 34px;\" colspan=\"2\">12. Remove empty medication syringe.\r\n\r\n&nbsp;\r\n\r\nClean access port using alcohol and friction for 15 seconds.\r\n\r\n&nbsp;\r\n\r\nLuer lock 10 ml saline filled syringe\u00a0 to the needleless cap.\u00a0Flush with volume directed by agency 's flushing protocol at the SAME rate as the medication delivery, according to guidelines found in the PDTM. (See <a href=\"#IVClearing\">Rationale for Flushing with NS after Administering an IV Medication<\/a>)\r\n\r\n&nbsp;\r\n\r\nEnsure the final flush is done in a way that ensures <strong>positive pressure<\/strong> is achieved. This will depend on what kind of needleless cap and what kind of saline filled syringe is available to you. <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\">See\u00a0 Positive Pressure<\/a>.\r\n\r\n&nbsp;<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 34px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.\r\n\r\nCheck agency flushing protocol for flushing volume.\r\n\r\nFlushing the IV line at the same rate as medication delivery ensures that any medication remaining within the IV line is delivered at the correct rate, and avoids the patient receiving an accidental bolus of the medication.\r\n\r\n[caption id=\"attachment_6186\" align=\"aligncenter\" width=\"190\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0926.jpg\"><img class=\"wp-image-6186\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/DSC_0926-300x199.jpg\" alt=\"Flushing extension tubing with NS at the same rate\" width=\"190\" height=\"126\" \/><\/a> Flush extension tubing with NS at the same rate as medication delivery[\/caption]\r\n\r\nFlushing the extension tubing clears the medication from the device.\r\n\r\n[caption id=\"attachment_2009\" align=\"aligncenter\" width=\"200\"]<img class=\"wp-image-2009 \" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/FAll-2018-003-300x205.jpg\" alt=\"\" width=\"200\" height=\"137\" \/> Figure 7.31 When flushing is complete, detach syringe from needleless cap. Apply clamp on extension tubing.[\/caption]\r\n\r\nNote: If a patient has a central venous catheter, follow agency protocols for accessing and flushing and locking.\r\n\r\n&nbsp;\r\n\r\nAlways assess IV sites before and after administration of IV medications.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 112px;\" colspan=\"2\">13. Dispose of all syringes, blunt fill needles, blunt fill filter needles according to agency policy.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 112px;\" colspan=\"2\">This prevents accidental needle-stick injuries.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 34px;\" colspan=\"2\">14. Perform hand hygiene.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 34px;\" colspan=\"2\">This reduces transmission of microorganisms.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; height: 16px; width: 358.2px;\" colspan=\"2\">15. Document as per agency protocol.<\/td>\r\n<td style=\"border: 1px solid #000000; height: 16px; width: 492.6px;\" colspan=\"2\">Document the time, reason, drug, dose, effect, and any adverse reactions.<\/td>\r\n<\/tr>\r\n<tr style=\"height: 57px;\">\r\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 57px;\" colspan=\"2\">16. Observe for expected therapeutic effect and for adverse effects.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 57px;\" colspan=\"2\">The patient needs to be evaluated and monitored, especially for high-alert medications. IV medications act rapidly.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 867.8px; height: 16px;\" colspan=\"4\">Data source:\u00a0Canadian Institute for Health Information, 2009; Clayton et al., 2010; Goossens, 2015; Perry et al., 2018<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<div class=\"textbox shaded\">Watch the video: <em>Administering Medications: <a href=\"https:\/\/barabus.tru.ca\/nursing\/administering_med_locked_iv.html\">Direct IV - Into a Locked IV (PVAD short) <\/a><\/em><span style=\"color: #333333;\">by Ren\u00e9e Anderson &amp; Wendy McKenzie Thompson Rivers University<\/span><\/div>\r\n<h5>Special considerations when giving meds IV:<\/h5>\r\n<ul>\r\n \t<li>Top contributing factors to medication errors include calculation errors, drug preparation errors, human error, and transcription inaccuracy.<\/li>\r\n \t<li>The elderly and the young may be more sensitive to adverse effects.<\/li>\r\n \t<li>With certain medications, creatinine clearance must be assessed prior to administering. Patients with liver disease may require a reduction in dosages.<\/li>\r\n \t<li>When a medication dose is ordered with a range (e.g., morphine 2 mg IV q 2-4 hours\u00a0p.r.n.), always start with the lowest dose and titrate up. Always assess when the last dose was given and its effectiveness.<\/li>\r\n<\/ul>\r\n<h2><a id=\"saline flushes after IV med administration\"><\/a><a id=\"IVClearing\"><\/a>Considerations for Saline Flushes <span style=\"text-decoration: underline;\">after<\/span> IV Medication Administration<\/h2>\r\n<ul>\r\n \t<li>The normal saline flush after IV meds are administered serves a few purposes: 1) to deliver any medication left in the tubing in to the patient;\u00a0 2) to reduce risk of residue - medications \/ IV solutions \/ fibrin- build up in the lumen of the IV cannula (Gossens, 2015); and 3) to establish an environment within the IV cannula to prevent reflux of blood\u00a0 and \/ or clotting of the VAD if it is to remain locked<\/li>\r\n \t<li>When meds are given IV direct, some medication remains in the tubing between the access port and the end of the IV cannula. As such care must be taken to complete the flush in a way that does not result in a bolus of medication being administered too quickly. Sudden boluses of some medications may cause mild to severe adverse effects, such as hypotension and toxicity (Clayton et al., 2010).<\/li>\r\n \t<li>The flushing solution must be compatible with other IV solutions \/ meds<\/li>\r\n \t<li>Turbulent flush is a stop start motion intended to cleanse the inside lumen of the IV cannula.<\/li>\r\n \t<li>High PSI (pounds per square inch) can fracture an IV cannula. Always use the manufacturers guidelines for choosing the syringe size (usually 10 ml).<\/li>\r\n \t<li>Refer to flushing protocols. Open ended CVADs require heparin after the saline flush to reduce risk of clotting.<\/li>\r\n<\/ul>\r\nHere are some examples of clearing IV medication from the extension tubing on a PVAD short saline lock.\r\n<ol>\r\n \t<li>If morphine (1 mg) is administered over one minute, the subsequent saline flush will be given in this manner: the <em>first 1 ml <\/em>of a 5 ml saline flush will be delivered over one minute to clear the medication from the tubing, and the remaining 4 ml will be the turbulent flush.<\/li>\r\n \t<li>If furosemide (40 mg) is given in a 4 ml volume and administered over two minutes, the subsequent saline flush will be given in this manner: the <em>first 1 ml<\/em> of a 5 ml saline flush will be delivered over 30 seconds, and the remaining 4 ml will be the turbulent flush.<\/li>\r\n<\/ol>\r\nChecklist 61 lists the steps to administering an IV medication through an existing IV line with compatible IV solution.\u00a0Review the preparation questions for intravenous medication in <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-6-intravenous-medications-by-direct-iv-formerly-iv-push\/\">Table 7.8<\/a> prior to the medication administration.\r\n<table style=\"border-color: #000000; height: 2914px; width: 100%;\" border=\"1px solid rgb(0, 0, 0)\">\r\n<tbody>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; text-align: center; height: 141px; width: 940.6px;\" colspan=\"4\">\r\n<h3 style=\"text-align: center;\">\u00a0 \u00a0 <a id=\"checklist61\"><\/a>Checklist 61: Administering medications IV direct into an infusing IV - with <strong>compatible<\/strong> solution\u00a0(PVAD short, midline, PICC, percutaneous non-hemodialysis CVC)<\/h3>\r\n<h5 style=\"text-align: center;\"><em><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your agency policy regarding this specific skill.<\/span><\/em><\/h5>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; height: 428px; width: 940.6px;\" colspan=\"4\">\r\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\r\n<ul>\r\n \t<li>Review the advantages and disadvantages of IV medications (Table 7.7)<\/li>\r\n \t<li>Be able to answer the preparation questions for intravenous medication in Table 7.9 before administering the medication.<\/li>\r\n \t<li>If the medication has been diluted and there is wastage, always discard unused diluted portion of the prepared IV medication before going to the bedside.<\/li>\r\n \t<li>Always follow agency policies and guidelines when preparing and administering medications<\/li>\r\n \t<li>Always label the syringe with 2 patient identifiers, date, time, medication, concentration of the dose, dose, and your initials. Once the medication is prepared, never leave it unattended.<\/li>\r\n \t<li>NEVER administer an IV medication through an IV line that is infusing blood, blood products, heparin IV, insulin IV, cytotoxic medications, or parenteral nutrition solutions.<\/li>\r\n \t<li>Never administer an IV medication into an IV line that isn't patent.<\/li>\r\n \t<li>Check compatibilities of the medication to with other medications \/ solutions in the same line<\/li>\r\n \t<li>Central venous catheters (midlines, percutaneous non-hemodialysis lines, PICC lines) may require special pre- and post-flushing procedures and specialized training.<\/li>\r\n \t<li>CVCs require at minimum a 10 ml syringe to decrease risk of catheter fracture.<\/li>\r\n \t<li>You will need a clock \/ timer\/ watch to time the rate of administration.<\/li>\r\n \t<li>Perform hand hygiene before preparing medications.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; text-align: center; height: 65px;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">Steps<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; text-align: center; height: 65px;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 511px;\" colspan=\"2\">1. Prepare one medication for one patient at the correct time as per agency policy. Review the physician's order, PDTM, and MAR for the correct order and guidelines. Math calculations may be required to determine the correct dose to prepare the medication.\r\n\r\n&nbsp;\r\n\r\nDetermine compatibilities of the medication to be given with the primary IV solution. If the primary solution contains medication that should not be stopped (e.g., heparin, morphine, pantoprazole, insulin, or blood or blood products),\u00a0\u00a0<strong>do not use this line. <\/strong>In this case establish another IV access.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 511px;\" colspan=\"2\">Always apply the SEVEN rights and THREE checks of medication administration.\r\n\r\nReview the agency policy if a medication is a stat, first-time, loading dose, or a one-time dose.\r\n\r\nSome agencies require high-alert medications to be double-checked by a second health care provider. Always follow agency policies.\r\n\r\nAfter preparing the medication, always label the medication syringe with two patient identifiers, date, time, medication, dose (e.g., morphine 2 mg), and your initials. Never leave the syringe unattended.\r\n\r\nIf medications given simultaneously are incompatible, the mixing of these can create precipitates in the IV tubing which can initiate emboli formation in the blood.\r\n\r\nStopping infusions that containing medications interrupts delivery of that medication.\r\n\r\nBlood and blood products are NOT compatible with ANY medication.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 16px;\" colspan=\"2\">2. Create privacy if possible.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 16px;\" colspan=\"2\">This provides comfort to patient.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 217px;\" colspan=\"2\">3. Confirm patient ID using two patient identifiers (e.g., name and date of birth) AND compare the MAR printout with the patient's wristband to confirm patient ID.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 217px;\" colspan=\"2\">This ensures you have the correct patient and complies with agency standard for patient identification.\r\n\r\n[caption id=\"attachment_6460\" align=\"aligncenter\" width=\"202\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-029.jpg\"><img class=\"wp-image-6460\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/06\/Sept-22-2015-029-300x163.jpg\" alt=\"Identify patient with two identifiers\" width=\"202\" height=\"110\" \/><\/a> Compare MAR to patient wristband[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 34px;\" colspan=\"2\">4. Check allergy band for any allergies, and ask patient about type and severity of reaction.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 34px;\" colspan=\"2\">This ensures allergy status is correct on the MAR and on patient allergy band.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 88px;\" colspan=\"2\">5. Discuss purpose, action, and possible side effects of the medication. Provide patient an opportunity to ask questions. Encourage patient to report discomfort at the IV site (pain, swelling, or burning).<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 88px;\" colspan=\"2\">Keeping patient informed of what is being administered helps decrease anxiety.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 56px;\" colspan=\"2\">6. <a href=\"http:\/\/opentextbc.ca\/clinicalskills\/chapter\/1-6-hand-hygiene\/\">Perform hand hygiene<\/a><\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 56px;\" colspan=\"2\">Prevents the transmission of microorganisms.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 14px;\" colspan=\"2\">7. Assess IV insertion site. See <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-5-iv-administration-equipment\/\">Checklist 65<\/a>.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 14px;\" colspan=\"2\">Redness, swelling and leaking suggest complications.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 316px;\" colspan=\"2\">8. Select IV access port closest to the patient. Clean access port using friction with an alcohol swab for 15 seconds. Allow to dry.\r\n\r\n[caption id=\"attachment_885\" align=\"aligncenter\" width=\"162\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-022.jpg\"><img class=\"wp-image-885\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-300x279.jpg\" alt=\"Clean port with an alcohol swab\" width=\"162\" height=\"150\" \/><\/a> Clean port with an alcohol swab[\/caption]<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 316px;\" colspan=\"2\">The closest port allows the medication to reach the blood stream quickly.\r\n\r\nCleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection. Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective.\r\n\r\nRefer to agency guidelines for VAD <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\">flushing &amp; locking protocols.<\/a><\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 104px;\" colspan=\"2\">9. Stop the infusion.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 104px;\" colspan=\"2\">Stopping the infusion for an IV run by gravity involves clamping a slide clamp distal to the access port or rolling the roller clamp to the closed position OR folding the tubing on itself and pinching it.\r\n\r\n&nbsp;\r\n\r\nStopping the infusion for an IV run by an EID \/ pump simply involves stopping the machine.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 256px;\" colspan=\"2\">10. Verify site patency.\r\n\r\n&nbsp;\r\n\r\nLuer lock a 10 ml saline filled syringe to the access port closest to the patient.\r\n\r\nAspirate and assess for blood flashback in the line. Forward flush 10 ml normal saline syringe using turbulent technique. THIS IS THE FLUSH PRIOR.\r\n\r\n&nbsp;\r\n\r\n<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0926.jpg\"><img class=\"wp-image-6186 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/DSC_0926-300x199.jpg\" alt=\"Flushing extension tubing with NS at the same rate\" width=\"262\" height=\"174\" \/><\/a><\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 256px;\" colspan=\"2\">\u00a0<strong>Checking patency of PVAD short<\/strong>: you can aspirate... or not. Likely you can assess patency through observation of the site with an infusing IV. PVAD short sites that are not patent may be edematous (suggests infiltration), may not be infusing (observe for drops in the drip chamber) or the EIDs \/ IV pumps alerts presence of an occlusion.\r\n\r\n&nbsp;\r\n\r\n<strong>Checking patency of midline, CVC (PICC \/ non-hemodialysis line)<\/strong>: aspirate for blood return. When blood flashback present in tubing, forward flush using turbulent technique. If there is no blood return, trouble shoot according to agency protocol and \/ or contact the IV team \/ PICC nurse for further assessment.\r\n\r\nUsing a needleless system prevents needle-stick injuries.\r\n\r\nNew recommendations include flushing before AND after medication administration.\r\n\r\n10 ml syringes decrease risk of catheter fracture. Flushing the line clears aspirated\u00a0 blood and reduces risk of clotting and occlusion. Turbulent flush cleans IV lumen of medication residue and fibrin. DO NOT force if resistance is felt.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 263px;\" colspan=\"2\">11.\u00a0Remove syringe.\r\n\r\n&nbsp;\r\n\r\nClean IV access port for 15 seconds with alcohol and friction. Allow to dry.\r\n\r\n&nbsp;\r\n\r\nLuer lock medication syringe to the access port.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 263px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.\r\n\r\n<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-028.jpg\"><img class=\"wp-image-888 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028-300x254.jpg\" alt=\"Inject IV medication slowly\" width=\"184\" height=\"155\" \/><\/a><\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 157px;\" colspan=\"2\">12. \u00a0Inject medication at the recommended rate according to PDTM. Use a timer \/ watch \/ clock to monitor time.\u00a0Administer the medication slow and steady. Attempt to have half of the syringe emptied in half of the recommended infusion time.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 157px;\" colspan=\"2\">Timing of the administration promotes safer medication delivery. Rapid injection of IV medications can have serious consequences for the patient<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 16px;\" colspan=\"2\">13.\u00a0Remove empty medication syringe.\r\n\r\n&nbsp;\r\n\r\nClean port using alcohol and friction.\r\n\r\n&nbsp;\r\n\r\nLuer lock a 10 ml saline filled syringe to the access port.\r\n\r\n&nbsp;\r\n\r\nFlush with volume directed by agency flushing protocol at the SAME rate as the medication delivery, according to guidelines found in the PDTM. (See <a href=\"#IVClearing\">Rationale for Flushing with NS after Administering an IV Medication<\/a>.) THIS IS THE FLUSH AFTER.\r\n\r\n&nbsp;\r\n\r\nResume the infusion.\r\n\r\n&nbsp;<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 16px;\" colspan=\"2\">\r\n\r\n[caption id=\"attachment_889\" align=\"aligncenter\" width=\"173\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-029.jpg\"><img class=\"wp-image-889\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029-300x259.jpg\" alt=\"Remove medication syringe\" width=\"173\" height=\"149\" \/><\/a> Remove medication syringe[\/caption]\r\n\r\n<span style=\"font-family: inherit; font-size: inherit;\">\u00a0Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective. Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.<\/span>\r\n<div class=\"mceTemp\">\r\n\r\nThe final flush does NOT have to ensure positive pressure is achieved because the infusion will be resumed.\r\n\r\n<\/div>\r\nAlways assess IV sites before and after administration of IV medications.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 52px;\" colspan=\"2\">14. Dispose of all syringes, and blunt fills and blunt fill filters as per agency protocol.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 52px;\" colspan=\"2\">Blunt fill and blunt fill filters are disposed of in sharps containers to\u00a0prevent accidental needle-stick injury.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 60px;\" colspan=\"2\">15.\u00a0<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/chapter\/1-6-hand-hygiene\/\">Perform hand hygiene<\/a>.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 60px;\" colspan=\"2\">This reduces transmission of microorganisms.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 34px;\" colspan=\"2\">16. Document as per agency protocol.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 34px;\" colspan=\"2\">Document time, reason, drug, dose, therapeutic effect, and any adverse reactions.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 52px;\" colspan=\"2\">17. Evaluate the patient for therapeutic effect and adverse reactions according to appropriate time frame (onset and peak of medication).<\/td>\r\n<td style=\"border: 1px solid #000000; width: 467px; height: 52px;\" colspan=\"2\">Observations provide additional safety measures, especially for high-alert medications. IV medications act rapidly.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 940.6px; height: 34px;\" colspan=\"4\">Data source: Berman &amp; Snyder, 2016; Canadian Institute for Health Information, 2009; Clayton et al., 2010; Perry et al., 2018;\u00a0Workers Compensation Act, 2015<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n&nbsp;\r\n<div class=\"textbox shaded\">Watch the video: <em><a href=\"https:\/\/barabus.tru.ca\/nursing\/administering_med_iv_infusion.html\">Administering Medications: Direct IV -\u00a0Into an IV with an Infusion<\/a>\u00a0<\/em> \u00a0<span style=\"color: #333333;\">by Ren\u00e9e Anderson &amp; Wendy McKenzie Thompson Rivers University<\/span><\/div>\r\nChecklist 62 reviews the steps to administer an IV medication through an existing IV line with incompatible IV solution.\u00a0Review the preparation questions for intravenous medication in <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-6-intravenous-medications-by-direct-iv-formerly-iv-push\/\">Table 7.8<\/a> prior to the medication administration.\r\n\r\n\u200b\r\n<table style=\"border-color: #000000; height: 2684px;\">\r\n<tbody>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; text-align: center; height: 191px; width: 978.2px;\" colspan=\"4\">\r\n<h3 style=\"text-align: center;\"><a id=\"checklist62\"><\/a><a id=\"checklist62\"><\/a>Checklist 62: Administering Medications IV Direct into an Infusing IV with <strong>Incompatible<\/strong> IV Solution\u00a0(PVAD Short, Midline, PICC, Percutaneous Non-Hemodialysis CVC)<\/h3>\r\n<h5 style=\"text-align: center;\"><em><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your agency policy regarding this specific skill.<\/span><\/em><\/h5>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; height: 480px; width: 978.2px;\" colspan=\"4\">\r\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\r\n<ul>\r\n \t<li>Review the advantages and disadvantages of IV medications (Table 7.8).<\/li>\r\n \t<li>Be able to answer the preparation questions for intravenous medication in Table 7.8 before administering the medication.<\/li>\r\n \t<li>If the medication has been diluted and there is wastage, always discard unused diluted portion of the prepared IV medication before going to the bedside.<\/li>\r\n \t<li>Always follow agency policies and guidelines when preparing and administering medications.<\/li>\r\n \t<li>Always label the syringe with 2 patient identifiers, date, time, medication, concentration of the dose, dose, and your initials. Once the medication is prepared, never leave it unattended.<\/li>\r\n \t<li>NEVER administer an IV medication through an IV line that is infusing blood, blood products, heparin IV, insulin IV, cytotoxic medications, or parenteral nutrition solutions.<\/li>\r\n \t<li>Never administer an IV medication into an IV line that isn't patent.<\/li>\r\n \t<li>Check compatibilities of the medication to the primary solution.<\/li>\r\n \t<li>Central venous catheters (midlines, percutaneous non-hemodialysis lines, PICC lines) may require special pre- and post-flushing procedures and specialized training.<\/li>\r\n \t<li>CVCs require at minimum a 10 ml syringe to decrease risk of catheter fracture.<\/li>\r\n \t<li>You will need a clock \/ watch\u00a0 timer to time the rate of administration.<\/li>\r\n \t<li>Perform hand hygiene before preparing medications.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; text-align: center; height: 65px;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">Steps<\/h4>\r\n<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; text-align: center; height: 65px;\" colspan=\"2\">\r\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\r\n<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 352px;\" colspan=\"2\">1. Prepare one medication for one patient at the correct time as per agency policy. Review the physician orders, PDTM, and MAR for the correct order and guidelines. Math calculations may be required to determine the correct dose to prepare the medication.\r\n\r\nAlways check agency policy to ensure an IV solution or medication can be stopped temporarily (i.e., longer than it takes to check patency).\u00a0<span style=\"font-family: inherit; font-size: inherit;\">Some IV solutions (i.e., those with medications in the primary solution\u2014insulin, heparin) can not be stopped. If unable to temporarily stop an IV solution or IV medication, establish a new IV access at a different site.<\/span><\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 352px;\" colspan=\"2\">Always apply the SEVEN rights THREE checks of medication administration.\r\n\r\nReview the agency policy if a medication is a stat, first-time, loading dose, or a one-time dose.\r\n\r\nSome agencies require that high-alert medications be double-checked by a second health care provider. Always follow agency policies.\r\n\r\nAfter preparing the medication, always label the medication syringe with two patient identifiers, date, time, medication and dose (e.g., morphine 2 mg), dose, and your initials. Never leave the syringe unattended.\r\n\r\n&nbsp;<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 16px;\" colspan=\"2\">2. Create privacy if possible.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 16px;\" colspan=\"2\">This provides comfort to patient.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 227px;\" colspan=\"2\">3. Confirm patient ID using two patient identifiers (e.g., name and date of birth) AND compare the MAR printout with the patient's wristband to confirm patient ID.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 227px;\" colspan=\"2\">This ensures you have the correct patient and complies with agency standard for patient identification.\r\n\r\n[caption id=\"attachment_6460\" align=\"aligncenter\" width=\"221\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-029.jpg\"><img class=\"wp-image-6460\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/06\/Sept-22-2015-029-300x163.jpg\" alt=\"Identify patient with two identifiers\" width=\"221\" height=\"120\" \/><\/a> Compare MAR to patient wristband[\/caption]<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 34px;\" colspan=\"2\">4. Check allergy band for any allergies, and ask patient about type and severity of reaction.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 34px;\" colspan=\"2\">This ensures allergy status is correct on the MAR and on patient allergy band.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 88px;\" colspan=\"2\">5. Discuss purpose, action, and possible side effects of the medication. Provide patient an opportunity to ask questions. Encourage patient to report discomfort at the IV site (pain, swelling, or burning).<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 88px;\" colspan=\"2\">Keeping patient informed of what is being administered helps decrease anxiety.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 34px;\" colspan=\"2\">6. Perform hand hygiene<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 34px;\" colspan=\"2\">Hand hygiene prevents the transmission of microorganisms.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 50px;\" colspan=\"2\">7. Assess IV insertion site. See <a style=\"font-family: inherit; font-size: inherit;\" href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-5-iv-administration-equipment\/\">Checklist 65\u00a0<\/a><\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 50px;\" colspan=\"2\">Redness, swelling and leaking suggest complications.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 291px;\" colspan=\"2\">8. Select IV access port closest to the patient. Clean access port using friction with an alcohol swab for 15 seconds. Allow to dry.\r\n\r\n[caption id=\"attachment_885\" align=\"aligncenter\" width=\"174\"]<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-022.jpg\"><img class=\"wp-image-885\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-300x279.jpg\" alt=\"Clean port with an alcohol swab\" width=\"174\" height=\"162\" \/><\/a> Clean port with an alcohol swab[\/caption]<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 291px;\" colspan=\"2\">The closest port allows the medication to reach the blood stream quickly.\r\n\r\n&nbsp;\r\n\r\nCleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection. Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective.\r\n\r\n&nbsp;\r\n\r\nRefer to agency guidelines for VAD <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\">flushing &amp; locking protocols.<\/a><\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 224px;\" colspan=\"2\">9. Stop the infusion.\r\n\r\n&nbsp;\r\n\r\n&nbsp;<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 224px;\" colspan=\"2\">Stopping the infusion for an IV run by gravity involves clamping a slide clamp distal to the access port or rolling the roller clamp to the closed position OR fold the tubing on itself and pinch\r\n\r\n&nbsp;\r\n\r\nStopping the infusion for an IV run by an EID \/ pump simply involves stopping the machine.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 276px;\" colspan=\"2\">10. Verify site patency\r\n\r\n&nbsp;\r\n\r\nLuer lock a 10 ml saline filled syringe to the access port closest to the patient. Aspirate and assess for blood flashback in the line. Forward flush 10 ml syringe using turbulent technique.\r\n\r\n&nbsp;\r\n\r\nTHIS FLUSH WILL CLEAR THE LINE OF THE INCOMPATIBLE MEDICATION.\r\n\r\n<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-025.jpg\"><img class=\"wp-image-890 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025-300x244.jpg\" alt=\"Flush IV line with NS\" width=\"175\" height=\"142\" \/><\/a><\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 276px;\" colspan=\"2\"><strong>Checking patency of PVAD short<\/strong>: you can aspirate... or not. Likely you can assess patency through observation of the site with an infusing IV.\r\n\r\nPVAD short sites that are not patent may be edematous (suggests infiltration) or not infusing (observe for drops in the drip chamber); or the IV pump\u00a0 indicates occlusion.\r\n\r\n&nbsp;\r\n\r\n<strong>Checking patency of midline, <\/strong><strong>CVC<\/strong><strong> (PICC \/ non-hemodialysis line)<\/strong>: aspirate for blood return. When blood flashback is present in tubing, forward flush using turbulent technique. If there is no blood return, trouble shoot according to agency protocol and \/ or contact the IV team \/ PICC nurse for further assessment.\r\n\r\n&nbsp;\r\n\r\nUsing a needleless system prevents needle-stick injuries.\r\n\r\n10 ml syringes decrease risk of catheter fracture. Flushing the line clears aspirated blood and reduces risk of clotting and occlusion and it clears the line of incompatible medication. Turbulent flush cleans IV lumen of medication residue and fibrin. DO NOT force if resistance is felt.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 113px;\" colspan=\"2\">11.\u00a0Remove syringe.\r\n\r\n&nbsp;\r\n\r\nClean IV access port for 15 seconds with alcohol and friction.\r\n\r\nAllow to dry.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 113px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.\r\n\r\n&nbsp;\r\n\r\nThe IV line must remain clamped (shut off) to avoid accidental mixing of incompatible IV solution and the medication.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 10px;\" colspan=\"2\">12. Leur lock the medication syringe to the access port.\r\n\r\nInject medication at the recommended rate according to PDTM. Use a timer \/ watch \/ clock to monitor time.\u00a0Administer the medication slow and steady. Attempt to have half of the syringe emptied in half of the recommended infusion time.\r\n\r\n&nbsp;\r\n\r\nRemove empty syringe. Clean port for 15 seconds using alcohol and friction.\r\n\r\nAttach a 10 ml normal saline syringe. Flush with volume directed by agency flushing protocol at the SAME rate as the medication delivery, according to guidelines found in the PDTM. (See <a href=\"#IVClearing#IVClearing\">Rationale for Flushing with NS after Administering an IV Medication<\/a>.) THIS FLUSH REMOVES MEDICATION FROM THE TUBING.\r\n\r\n&nbsp;\r\n\r\n&nbsp;<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 10px;\" colspan=\"2\">This ensures safe medication administration at the correct rate. Rapid injection of IV medications can have serious consequences for the patient\r\n\r\n&nbsp;\r\n\r\nAlways assess IV sites before and after administration of IV medications.\r\n\r\n&nbsp;\r\n\r\nThis step delivers the medication that remains in the IV tubing at the same rate, and prevents patient from accidentally receiving a bolus of the medication. It also\u00a0clears the IV line to prevent any mixing of incompatible medication with the IV solution.\r\n\r\nThe IV line must remain clamped to avoid accidental mixing of incompatible IV solution and the medication.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 10px;\" colspan=\"2\">13. Resume the IV infusion\r\n<ul>\r\n \t<li>Gravity infusion:\u00a0Unclamp IV line and regulate the rate using the roller clamp.<\/li>\r\n \t<li>EID \/ pump infusion: Restart IV infusion device.<\/li>\r\n<\/ul>\r\nAssess the IV site.\r\n\r\n&nbsp;<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 10px;\" colspan=\"2\"><img class=\"wp-image-4877 alignleft\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2019\/09\/Baxter_Colleague_CX_infusion_pump-225x300.jpg\" alt=\"\" width=\"120\" height=\"160\" \/><img class=\"wp-image-891 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Sept-22-2015-086-199x300-199x300.jpg\" alt=\"\" width=\"118\" height=\"177\" \/>\r\n\r\n<span style=\"font-size: 1.125rem; font-family: inherit;\">Resume the IV infusion\u00a0<\/span><\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 155px;\" colspan=\"2\">14.\u00a0Dispose of all syringes and blunt fills and blunt fill filters as per agency protocol.\r\n\r\n&nbsp;\r\n\r\nPerform hand hygiene.<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 155px;\" colspan=\"2\">Blunt fill and blunt fill filters are disposed of in sharps containers to\u00a0prevent accidental needle-stick injury.\r\n\r\n&nbsp;\r\n\r\nThis reduces the transmission of microorganisms.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 52px;\" colspan=\"2\">15. Evaluate the patient's response to the medication in the appropriate time frame.\r\n\r\nDocument according to agency protocol<\/td>\r\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 52px;\" colspan=\"2\">Observe patient for expected therapeutic effects and adverse reactions.\r\n\r\nObservations provide additional safety measures, especially for high-alert medications. IV medications act rapidly.<\/td>\r\n<\/tr>\r\n<tr style=\"border-color: #000000;\">\r\n<td style=\"border: 1px solid #000000; width: 978.2px; height: 16px;\" colspan=\"4\">Data source: Berman &amp; Snyder, 2016; Canadian Institute for Health Information, 2009; Clayton et al., 2010; Perry et al., 2014<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<div><\/div>\r\n<div class=\"bcc-box bcc-info\">\r\n<h3 style=\"text-align: center;\">Critical Thinking Exercises<\/h3>\r\n<ol>\r\n \t<li>Find a resource that will advise you about onset, peak, and duration of morphine IV.<\/li>\r\n \t<li>What information should be on the label of an IV medication syringe after it is prepared?<\/li>\r\n<\/ol>\r\n<h1>Attributions<\/h1>\r\nFigure 7.20 Cleaning access port by author is\u00a0licensed under a\u00a0<a href=\"http:\/\/creativecommons.org\/licenses\/by\/4.0\/\">Creative Commons Attribution 4.0 International License<\/a>.\r\n\r\nFigure 7.30 Leur lock syringe to needleless cap by author\u00a0is licensed under a\u00a0<a href=\"http:\/\/creativecommons.org\/licenses\/by\/4.0\/\">Creative Commons Attribution 4.0 International License<\/a>.\r\n\r\nFigure 7.31 Apply slide clamp by author\u00a0is licensed under a\u00a0<a href=\"http:\/\/creativecommons.org\/licenses\/by\/4.0\/\">Creative Commons Attribution 4.0 International License<\/a>.\r\n\r\nFigure 7.32 <a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:%CE%9F%CE%B3%CE%BA%CE%BF%CE%BC%CE%B5%CF%84%CF%81%CE%B9%CE%BA%CE%AE_%CE%B1%CE%BD%CF%84%CE%BB%CE%AF%CE%B1_%CF%87%CE%BF%CF%81%CE%AE%CE%B3%CE%B7%CF%83%CE%B7%CF%82_%CF%85%CE%B3%CF%81%CF%8E%CE%BD.png\">Volumetric infusion pump<\/a> by <a href=\"https:\/\/commons.wikimedia.org\/w\/index.php?title=%CE%A3%CF%84%CE%AD%CE%BB%CE%B9%CE%BF%CF%82_%CE%A0%CE%B1%CF%81%CE%B9%CF%83%CF%83%CF%8C%CF%80%CE%BF%CF%85%CE%BB%CE%BF%CF%82,_%CE%95%CE%A0_%CE%A4%CE%95%CE%99_%CE%91%CE%B8%CE%AE%CE%BD%CE%B1%CF%82&amp;action=edit&amp;redlink=1\">\r\n\u03a3\u03c4\u03ad\u03bb\u03b9\u03bf\u03c2 \u03a0\u03b1\u03c1\u03b9\u03c3\u03c3\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2, \u0395\u03a0 \u03a4\u0395\u0399 \u0391\u03b8\u03ae\u03bd\u03b1\u03c2<\/a> is licensed under a\u00a0<a href=\"https:\/\/en.wikipedia.org\/wiki\/en:Creative_Commons\">Creative Commons<\/a>\u00a0<a href=\"https:\/\/creativecommons.org\/licenses\/by-sa\/3.0\/deed.en\">Attribution-Share Alike\u00a0<\/a>3.0 license\r\n\r\n<\/div>","rendered":"<p>In the past, IV medications given as described above were referred to as IV bolus or IV push medications. It is recommended that these terms NOT be used, as they can be mistakenly interpreted as meaning the drugs are to be pushed quickly, in less than a minute (ISMP, 2003). To administer IV medications safely and effectively, nurses must follow all\u00a0 agency policies and use\u00a0PDTM guidelines to determine which\u00a0medications can be given intravenously and any specific instructions about administration (Alberta Health Services, 2009).<\/p>\n<p>Intravenous (IV)\u00a0is a route for administering concentrated medications (diluted or undiluted) directly into the vein. Depending on the medication and the purpose, meds given IV may be through continuous infusions, mini-bags, or more quickly by what is referred to as direct IV.\u00a0 The IV direct route refers to the administration of a small volume of fluid \/ medication (max. 20 ml) pushed manually into the patient using a syringe Leur locked to a needleless port. Medications given by direct IV are usually administered intermittently to treat emergent concerns. Medications administered by direct IV route are given very slowly over at least one minute (Perry et al., 2014). The nurse must consult drug monographs and \/ or Parenteral Drug Therapy Manual (PDTM) for specifics about each medication. Administering a medication intravenously eliminates the process of drug first pass by depositing the medication directly into the blood. This results in the immediate elevation of serum drug levels and high drug concentrations in vital organs, such as the heart, brain and kidneys. Both therapeutic and adverse effects can occur quickly with IV direct administration (Alberta Health Services, 2009).\u00a0 <span style=\"text-indent: 1em; font-size: 14pt;\">\u00a0<\/span><\/p>\n<p>There are many advantages and disadvantages to administering medications via the intravenous injection method\u2014see\u00a0Table 7.7.<\/p>\n<table style=\"height: 662px;\">\n<tbody>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000; text-align: left;\" colspan=\"4\">\n<h3 style=\"text-align: center;\"><a id=\"table7.7\"><\/a>Table 7.7 Advantages\u00a0and Disadvantages of Intravenous Medications<\/h3>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">Advantages<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">Disadvantages<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Intravenous medications can deliver an immediate, fast-acting therapeutic effect, which is important in emergent situations such as cardiac arrest or narcotic overdose.\u00a0They are useful to manage pain and nausea by quickly achieving therapeutic levels, and they are\u00a0more consistently and completely absorbed compared with medications given by other routes of injection.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Once an intravenous medication is delivered, it cannot be retrieved.\u00a0When giving IV medications, there is very little opportunity to stop an injection if an adverse reaction or error occurs. IV medications, if given too quickly or incorrectly, can cause significant harm or death.<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Doses of short-acting medication can be titrated according to patient responses to drug therapy. Medication can be prepared quickly, and given over a shorter period of time compared to the IV piggyback route.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Any toxic or adverse reaction will occur immediately and may be exacerbated by a rapidly injected medication.<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Minimal dilution is required for some medications, which is desirable for patient&#8217;s own fluid restrictions.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Extravasation of certain medications into surrounding tissues can cause tissue damage, nerve damage, and scarring.<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">There is minimal or no discomfort for the patient in comparison to SC and IM injections.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Not all medications can be given via the direct IV route.<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">They provide an alternative\u00a0to the oral route for drugs that may not be absorbed by the GI tract, and they are ideal for patients with GI dysfunction or malabsorption, and patients who are NPO (nothing by mouth) or unconscious.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">There is a high risk for infusion reactions,\u00a0mild to severe, because most IV medications peak rapidly (i.e., they have a quick onset of effect).\u00a0A hypersensitivity reaction can occur immediately or be delayed, and requires supportive measures.<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">IV direct route provides a more accurate dose of medication because none is left in the intravenous tubing.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Route for administering medications may damage surrounding tissues. There is an increased risk of phlebitis with highly concentrated medication, especially with small peripheral veins or a short venous access device.<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"4\">Data source:\u00a0Albert Health Services, 2009; Lynn, 2011;\u00a0Perry et al., 2018<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Intravenous medications are always prepared using the SEVEN rights and THREE checks as per agency policy. Because of the high risk associated with direct intravenous medications, additional guidelines are required. A PDTM or drug monograph provides additional information to help the nurse make decisions about administering IV medications. Some medications can be given either IV direct or piggyback, in which case the nurse must use their knowledge about the patient to determine which of these is preferred. Some medications may only be given in\u00a0 large-volume IV solutions; some medications have to be diluted; some medications have to be administered over specific time frames (i.e., over 1 or 2 minutes). In addition, information regarding indications, contraindications, dosage (age dependent), administration\/dilution guidelines, adverse effects, clinical indications (e.g., specialized monitoring required, must be on an IV pump), compatibility and incompatibility in relation to reconstitution and primary IV solution is specified (Alberta Health Services, 2009).<\/p>\n<p>The Institute for Safe Medication Practices (ISMP) (2014) has created a list of high-alert medications that bear the heightened risk of significant harm when they are used in error. Special safeguards for these medications can be found in the PDTM. It is vital to understand which medications are considered high risk prior to administration. A link to the list of high-risk medications can be found under S<a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-9-summary\/\">uggested Online Resources<\/a> at the end of this chapter.\u00a0Review the steps shown in Table 7.8 to prepare a medication by direct IV route.\u00a0The PDTM must be consulted every time an IV medication is given, as memory-based errors are common (World Health Organization, 2012).<\/p>\n<table>\n<tbody>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000; text-align: left;\" colspan=\"4\">\n<h3 style=\"text-align: center;\"><a id=\"table7.8\"><\/a>Table 7.8 Preparation Questions for Intravenous Medications<\/h3>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000; text-align: left;\" colspan=\"4\">\n<h5>Safety considerations:<\/h5>\n<ul>\n<li>Be diligent and follow all policies related to medication calculations, preparation, and thorough assessment of patient status before and after an injection. Medication errors are the most common preventable errors in health care.<\/li>\n<li>Use a blunt filter needle or blunt needle when preparing injections. Never use a needle when injecting IV medication. Always use a needleless system.<\/li>\n<li>After preparing the medication, always label the medication syringe with two patient identifiers, date, time, medication, dose, and your initials. Never leave the syringe unattended.<\/li>\n<li>Correctly identify the VAD, and use agency flushing and locking protocols for correct administration.<\/li>\n<li>Always administer the post-saline lock flush at the SAME RATE as the IV medication.<\/li>\n<li>Always assess the patient&#8217;s symptoms and need for IV medication prior to administration.<\/li>\n<li>Always assess the patient&#8217;s understanding of the medication.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">Principle<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">Additional Information<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Verify qualifications for administration.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\n<p style=\"text-align: left;\">Are you qualified to give this medication? What supervision is required? What resources must you consult?<\/p>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Review route of administration and IV site.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">\n<p style=\"text-align: left;\">Can this medication be given by the IV route? Is the route of administration (needle insertion site) free from redness, swelling, and discomfort?<\/p>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Review preparation and how to administer the medication.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">How is this medication given by the IV route (diluted or undiluted)? Describe the safest way to prepare the medication. Consider the selection of medication. Always use less-concentrated solutions whenever possible. Does the medication require dilution? If diluting the medication, ALWAYS discard (that is, waste) the unused portion before going to the bedside.<\/p>\n<ul>\n<li>Preparation and supplies:\u00a0is a pre-flush required?<\/li>\n<li>Patient identification:\u00a0any allergies?<\/li>\n<li>Administration rate:\u00a0what is the correct rate of administration (over 1 minute, 5 minutes)?<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Identify when a medication starts to work.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">What is the onset, peak, and duration of the medication?<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Assess dose and range (e.g., 5 to\u00a010 mg).<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Is the ordered dose safe? When did the patient last receive this medication? What was the effect of the medication on the patient?<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Understand the therapeutic effect.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">What is the expected therapeutic effect of the medication? What assessment is necessary to determine if the medication is correct for the patient?<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Know adverse effects.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">What are the potential adverse effects of the medications? How would you manage these adverse effects? Is there an antidote?<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Know potential incompatibilities.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Are there any potential incompatibilities with existing IV solutions? How would you manage these issues? Is a secondary medication currently running? Are there additives to the IV solution?<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Know how to complete the\u00a0procedure.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">How do you complete this procedure? Is a post-saline lock flush required?<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">Document procedure.<\/td>\n<td style=\"border: 1px solid #000000;\" colspan=\"2\">How and where do you chart this medication: pain assessment sheet, MAR, etc.?<\/td>\n<\/tr>\n<tr style=\"border: 1px solid #000000;\">\n<td style=\"border: 1px solid #000000;\" colspan=\"4\">Data source: BCIT, 2015; Berman &amp; Snyder, 2016; Clayton et al., 2010; WHO, 2012<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Before giving an intravenous medication, always assess the IV insertion site for patency and for signs of infiltration or phlebitis. Start a new IV site if current site is red, swollen, or painful when flushing. Intravenous medications by direct IV route can be given three ways:<\/p>\n<ul>\n<li>Through an IV that is capped \/ locked.<\/li>\n<li>Through an IV that has an infusion running and the medication is compatible with the IV solution.<\/li>\n<li>Through an IV that has an infusion running and the medication is incompatible with the IV solution.<\/li>\n<\/ul>\n<p>Checklist 60 reviews the steps to administer a medication IV direct into a locked \/ capped IV. Review the preparation questions for intravenous medication in <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-6-intravenous-medications-by-direct-iv-formerly-iv-push\/\">Table 7.8 <\/a>prior to administering medication.<\/p>\n<table style=\"border-color: #000000; height: 2977px; width: 100%;\">\n<tbody>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 867.8px; text-align: center; height: 116px;\" colspan=\"4\">\n<h3 style=\"text-align: center;\"><a id=\"checklist60\"><\/a>Checklist 60: Administering Medications IV Direct into a Locked \/ Capped IV\u00a0(PVAD Short, Midline, PICC, Percutaneous Non-Hemodialysis CVC)<\/h3>\n<h5 style=\"text-align: center;\"><em><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your agency policy regarding this specific skill.<\/span><\/em><\/h5>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 867.8px; height: 375px;\" colspan=\"4\">\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\n<ul>\n<li>Review the advantages and disadvantages of IV medications.<\/li>\n<li>Be able to answer the preparation questions for intravenous medication in Table 7.9 before administering the medication.<\/li>\n<li>If the medication has been diluted and there is wastage, always discard unused diluted portion of the prepared IV medication before going to the bedside.<\/li>\n<li>Always label the IV syringe with two patient identifiers, date, time, medication, dose, and your initials. Once the medication is prepared, never leave it unattended.<\/li>\n<li>Never administer an IV medication into an IV line that isn&#8217;t patent.<\/li>\n<li>Central venous catheters (percutaneous non-hemodialysis lines, PICC lines) and midline catheters may require special pre- and post-flushing procedures and specialized training.<\/li>\n<li>Always follow agency policies and guidelines when preparing and administering medications.<\/li>\n<li>CVCs require at minimum a 10 ml syringe to decrease risk of catheter fracture.<\/li>\n<li>If using prefilled saline syringes, remove air prior.<\/li>\n<li>You will need a clock . watch \/ timer to time the rate of administration.<\/li>\n<li>Perform hand hygiene before preparing medications.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; text-align: center; height: 65px;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">Steps<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; text-align: center; height: 65px;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 352px;\" colspan=\"2\">1. Prepare one medication for one patient at the correct time as per agency policy. Review the physician&#8217;s order, PDTM, and MAR for the correct order and guidelines. Math calculations may be required to determine the correct dose to prepare the medication.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 352px;\" colspan=\"2\">Always apply the SEVEN rights and THREE checks of medication administration.<\/p>\n<p>Review the agency policy if a medication is a stat, given for the first time, a loading dose, or a one-time dose.<\/p>\n<p>Some agencies require that high-alert medications be double-checked by a second health care provider. Always follow agency policies. For a list of high-alert medications, see <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-9-summary\/\">Suggested Online Resources.<\/a><\/p>\n<p>After preparing the medication, always label the medication syringe with two patient identifiers (name &amp; date of birth), date, time, medication, dose (ie. 2 mg), and your initials. Never leave the medication syringe unattended.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 16px;\" colspan=\"2\">2. Create privacy if possible.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 16px;\" colspan=\"2\">This provides comfort to patient.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 242px;\" colspan=\"2\">3. Confirm patient ID using two patient identifiers (e.g., name and date of birth) AND compare the MAR with the patient&#8217;s wristband to confirm patient ID.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 242px;\" colspan=\"2\">This ensures you have the correct patient and complies with agency standard for patient identification.<\/p>\n<figure id=\"attachment_6143\" aria-describedby=\"caption-attachment-6143\" style=\"width: 152px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Book-pictures-2015-430.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6143\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Book-pictures-2015-430-300x231.jpg\" alt=\"Compare MAR with patient name band\" width=\"152\" height=\"117\" \/><\/a><figcaption id=\"caption-attachment-6143\" class=\"wp-caption-text\">Compare MAR with patient wristband<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 34px;\" colspan=\"2\">4. Check allergy band for any allergies, and ask patient about type and severity of reaction.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 34px;\" colspan=\"2\">This ensures allergy status is correct on the MAR and on patient&#8217;s allergy band.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 88px;\" colspan=\"2\">5. Discuss purpose, action, and possible side effects of the medication. Provide patient an opportunity to ask questions. Encourage patient to report discomfort at the IV site (pain, swelling, or burning).<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 88px;\" colspan=\"2\">Keeping the patient informed of what is being administered helps decrease anxiety.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 79px;\" colspan=\"2\">6. Perform hand hygiene<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 79px;\" colspan=\"2\">Hand hygiene prevents the transmission of microorganisms.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 222px;\" colspan=\"2\">7. Assess IV insertion site for complications. See <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-5-iv-administration-equipment\/\">Checklist 65<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p>Clean access port \/ needleless cap using alcohol and friction for 15 seconds. Allow to dry.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 222px;\" colspan=\"2\">Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective. Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.<\/p>\n<figure id=\"attachment_1950\" aria-describedby=\"caption-attachment-1950\" style=\"width: 232px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1950\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-014-300x194.jpg\" alt=\"\" width=\"232\" height=\"150\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-014-300x194.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-014-65x42.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-014-225x146.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-014-350x227.jpg 350w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-014.jpg 509w\" sizes=\"auto, (max-width: 232px) 100vw, 232px\" \/><figcaption id=\"caption-attachment-1950\" class=\"wp-caption-text\">Figure 7.29 Clean access port<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 326px;\" colspan=\"2\">8.\u00a0 Luer lock 10 ml saline filled syringe onto needleless cap. Release clamp on extension tubing if present.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 326px;\" colspan=\"2\">10 ml syringes for flushing reduces risk of fracturing the IV cannula.<\/p>\n<figure id=\"attachment_1943\" aria-describedby=\"caption-attachment-1943\" style=\"width: 235px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1943\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-002-300x167.jpg\" alt=\"\" width=\"235\" height=\"131\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-002-300x167.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-002-65x36.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-002-225x125.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-002-350x194.jpg 350w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2018\/08\/FAll-2018-002.jpg 600w\" sizes=\"auto, (max-width: 235px) 100vw, 235px\" \/><figcaption id=\"caption-attachment-1943\" class=\"wp-caption-text\">Figure 7.30 Luer lock saline syringe onto needleless cap<\/figcaption><\/figure>\n<figure id=\"attachment_6188\" aria-describedby=\"caption-attachment-6188\" style=\"width: 199px\" class=\"wp-caption alignright\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0928.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6188\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/DSC_0928-300x199.jpg\" alt=\"Release clamp\" width=\"199\" height=\"132\" \/><\/a><figcaption id=\"caption-attachment-6188\" class=\"wp-caption-text\">Release clamp if present<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Refer to agency guidelines for VAD<a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\"> flushing &amp; locking protocols.<\/a><\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 239px;\" colspan=\"2\">9. Verify <strong>patency<\/strong> of the line.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>PVAD short:<\/strong><\/p>\n<ul>\n<li>You can aspirate&#8230;or not.<\/li>\n<li>Forward flush normal saline (follow agency flushing protocol\u2014usually 2 to 5 ml turbulent flush).<\/li>\n<\/ul>\n<p><strong>Midline, CVC (PICC \/ percutaneous non-hemodialysis line):<\/strong><\/p>\n<ul>\n<li>Aspirate for blood return. When blood flashback present in tubing forward flush using turbulent technique (follow agency flushing protocol\u2014usually 10 ml 0.9%NS).<\/li>\n<li>Do not force if resistance is felt.<\/li>\n<\/ul>\n<p>Remove syringe.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 239px;\" colspan=\"2\">PVAD short: if swelling, pain, or redness exists, remove IV cannula and reestablish new IV site. Tenderness is the first sign of phlebitis.<\/p>\n<p>Aspirating on a PVAD short often does not reveal blood flashback despite the site being patent. Assess for patency of PVAD short during the flush by assessing for resistance, pain, and leaking. If you suspect the line is not patent, STOP. DO NOT forward flush. Remove the PVAD short and reestablish a new one.<\/p>\n<p>Turbulent flush is a stop start vigorous motion intended to clean the inside lumen of the VAD.<\/p>\n<p>&nbsp;<\/p>\n<p>Aspirating on a PICC, midline, and percutaneous non-hemodialysis CVC should reveal blood flashback. If you suspect the line is not patent, or partially occluded, follow agency guidelines (this usually involves trouble shooting and \/ or consulting the IV team \/ PICC nurse for declotting).<\/p>\n<p>If possible, aspirate only until flashback of blood is into the catheter. Flashback into syringe creates more risk for occlusion if not flushed correctly.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 257px;\" colspan=\"2\">10. Clean access port with alcohol and friction for 15 seconds.<\/p>\n<p>&nbsp;<\/p>\n<p>Luer lock medication syringe\u00a0 to needleless cap.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 257px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.<\/p>\n<p>Using a needleless system prevents needle-stick injuries.<\/p>\n<p>Use 10 ml syringe (minimum) to reduce risk of catheter fracture.<\/p>\n<figure id=\"attachment_9403\" aria-describedby=\"caption-attachment-9403\" style=\"width: 200px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/11\/IMG_6604.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-880\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6604-300x225.jpg\" alt=\"IMG_6604\" width=\"200\" height=\"150\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6604-300x225.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6604-65x49.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6604-225x169.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6604.jpg 320w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-9403\" class=\"wp-caption-text\">Luer lock medication filled syringe to the needleless cap<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 297px;\" colspan=\"2\">11.\u00a0Use a timer \/ watch \/ clock to inject medication at the correct rate according to agency policy. Administer the medication slowly and steadily. Attempt to have half of the syringe emptied in half of the recommended infusion time.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 297px;\" colspan=\"2\">Timing of the administration promotes safer medication administration. Rapid injection of IV medications can have serious consequences for the patient.<\/p>\n<figure id=\"attachment_9404\" aria-describedby=\"caption-attachment-9404\" style=\"width: 200px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/11\/IMG_6607.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-881\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6607-300x225.jpg\" alt=\"Inject medication into saline lock\" width=\"200\" height=\"150\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6607-300x225.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6607-65x49.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6607-225x169.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/IMG_6607.jpg 320w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-9404\" class=\"wp-caption-text\">Inject medication into the venous access device<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 34px;\" colspan=\"2\">12. Remove empty medication syringe.<\/p>\n<p>&nbsp;<\/p>\n<p>Clean access port using alcohol and friction for 15 seconds.<\/p>\n<p>&nbsp;<\/p>\n<p>Luer lock 10 ml saline filled syringe\u00a0 to the needleless cap.\u00a0Flush with volume directed by agency &#8216;s flushing protocol at the SAME rate as the medication delivery, according to guidelines found in the PDTM. (See <a href=\"#IVClearing\">Rationale for Flushing with NS after Administering an IV Medication<\/a>)<\/p>\n<p>&nbsp;<\/p>\n<p>Ensure the final flush is done in a way that ensures <strong>positive pressure<\/strong> is achieved. This will depend on what kind of needleless cap and what kind of saline filled syringe is available to you. <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\">See\u00a0 Positive Pressure<\/a>.<\/p>\n<p>&nbsp;<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 34px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.<\/p>\n<p>Check agency flushing protocol for flushing volume.<\/p>\n<p>Flushing the IV line at the same rate as medication delivery ensures that any medication remaining within the IV line is delivered at the correct rate, and avoids the patient receiving an accidental bolus of the medication.<\/p>\n<figure id=\"attachment_6186\" aria-describedby=\"caption-attachment-6186\" style=\"width: 190px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0926.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6186\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/DSC_0926-300x199.jpg\" alt=\"Flushing extension tubing with NS at the same rate\" width=\"190\" height=\"126\" \/><\/a><figcaption id=\"caption-attachment-6186\" class=\"wp-caption-text\">Flush extension tubing with NS at the same rate as medication delivery<\/figcaption><\/figure>\n<p>Flushing the extension tubing clears the medication from the device.<\/p>\n<figure id=\"attachment_2009\" aria-describedby=\"caption-attachment-2009\" style=\"width: 200px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-2009\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/FAll-2018-003-300x205.jpg\" alt=\"\" width=\"200\" height=\"137\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/FAll-2018-003-300x205.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/FAll-2018-003-65x44.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/FAll-2018-003-225x154.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/FAll-2018-003-350x239.jpg 350w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/FAll-2018-003.jpg 600w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><figcaption id=\"caption-attachment-2009\" class=\"wp-caption-text\">Figure 7.31 When flushing is complete, detach syringe from needleless cap. Apply clamp on extension tubing.<\/figcaption><\/figure>\n<p>Note: If a patient has a central venous catheter, follow agency protocols for accessing and flushing and locking.<\/p>\n<p>&nbsp;<\/p>\n<p>Always assess IV sites before and after administration of IV medications.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 112px;\" colspan=\"2\">13. Dispose of all syringes, blunt fill needles, blunt fill filter needles according to agency policy.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 112px;\" colspan=\"2\">This prevents accidental needle-stick injuries.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 34px;\" colspan=\"2\">14. Perform hand hygiene.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 34px;\" colspan=\"2\">This reduces transmission of microorganisms.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; height: 16px; width: 358.2px;\" colspan=\"2\">15. Document as per agency protocol.<\/td>\n<td style=\"border: 1px solid #000000; height: 16px; width: 492.6px;\" colspan=\"2\">Document the time, reason, drug, dose, effect, and any adverse reactions.<\/td>\n<\/tr>\n<tr style=\"height: 57px;\">\n<td style=\"border: 1px solid #000000; width: 358.2px; height: 57px;\" colspan=\"2\">16. Observe for expected therapeutic effect and for adverse effects.<\/td>\n<td style=\"border: 1px solid #000000; width: 492.6px; height: 57px;\" colspan=\"2\">The patient needs to be evaluated and monitored, especially for high-alert medications. IV medications act rapidly.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 867.8px; height: 16px;\" colspan=\"4\">Data source:\u00a0Canadian Institute for Health Information, 2009; Clayton et al., 2010; Goossens, 2015; Perry et al., 2018<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"textbox shaded\">Watch the video: <em>Administering Medications: <a href=\"https:\/\/barabus.tru.ca\/nursing\/administering_med_locked_iv.html\">Direct IV &#8211; Into a Locked IV (PVAD short) <\/a><\/em><span style=\"color: #333333;\">by Ren\u00e9e Anderson &amp; Wendy McKenzie Thompson Rivers University<\/span><\/div>\n<h5>Special considerations when giving meds IV:<\/h5>\n<ul>\n<li>Top contributing factors to medication errors include calculation errors, drug preparation errors, human error, and transcription inaccuracy.<\/li>\n<li>The elderly and the young may be more sensitive to adverse effects.<\/li>\n<li>With certain medications, creatinine clearance must be assessed prior to administering. Patients with liver disease may require a reduction in dosages.<\/li>\n<li>When a medication dose is ordered with a range (e.g., morphine 2 mg IV q 2-4 hours\u00a0p.r.n.), always start with the lowest dose and titrate up. Always assess when the last dose was given and its effectiveness.<\/li>\n<\/ul>\n<h2><a id=\"saline flushes after IV med administration\"><\/a><a id=\"IVClearing\"><\/a>Considerations for Saline Flushes <span style=\"text-decoration: underline;\">after<\/span> IV Medication Administration<\/h2>\n<ul>\n<li>The normal saline flush after IV meds are administered serves a few purposes: 1) to deliver any medication left in the tubing in to the patient;\u00a0 2) to reduce risk of residue &#8211; medications \/ IV solutions \/ fibrin- build up in the lumen of the IV cannula (Gossens, 2015); and 3) to establish an environment within the IV cannula to prevent reflux of blood\u00a0 and \/ or clotting of the VAD if it is to remain locked<\/li>\n<li>When meds are given IV direct, some medication remains in the tubing between the access port and the end of the IV cannula. As such care must be taken to complete the flush in a way that does not result in a bolus of medication being administered too quickly. Sudden boluses of some medications may cause mild to severe adverse effects, such as hypotension and toxicity (Clayton et al., 2010).<\/li>\n<li>The flushing solution must be compatible with other IV solutions \/ meds<\/li>\n<li>Turbulent flush is a stop start motion intended to cleanse the inside lumen of the IV cannula.<\/li>\n<li>High PSI (pounds per square inch) can fracture an IV cannula. Always use the manufacturers guidelines for choosing the syringe size (usually 10 ml).<\/li>\n<li>Refer to flushing protocols. Open ended CVADs require heparin after the saline flush to reduce risk of clotting.<\/li>\n<\/ul>\n<p>Here are some examples of clearing IV medication from the extension tubing on a PVAD short saline lock.<\/p>\n<ol>\n<li>If morphine (1 mg) is administered over one minute, the subsequent saline flush will be given in this manner: the <em>first 1 ml <\/em>of a 5 ml saline flush will be delivered over one minute to clear the medication from the tubing, and the remaining 4 ml will be the turbulent flush.<\/li>\n<li>If furosemide (40 mg) is given in a 4 ml volume and administered over two minutes, the subsequent saline flush will be given in this manner: the <em>first 1 ml<\/em> of a 5 ml saline flush will be delivered over 30 seconds, and the remaining 4 ml will be the turbulent flush.<\/li>\n<\/ol>\n<p>Checklist 61 lists the steps to administering an IV medication through an existing IV line with compatible IV solution.\u00a0Review the preparation questions for intravenous medication in <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-6-intravenous-medications-by-direct-iv-formerly-iv-push\/\">Table 7.8<\/a> prior to the medication administration.<\/p>\n<table style=\"border-color: #000000; height: 2914px; width: 100%;\">\n<tbody>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; text-align: center; height: 141px; width: 940.6px;\" colspan=\"4\">\n<h3 style=\"text-align: center;\">\u00a0 \u00a0 <a id=\"checklist61\"><\/a>Checklist 61: Administering medications IV direct into an infusing IV &#8211; with <strong>compatible<\/strong> solution\u00a0(PVAD short, midline, PICC, percutaneous non-hemodialysis CVC)<\/h3>\n<h5 style=\"text-align: center;\"><em><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your agency policy regarding this specific skill.<\/span><\/em><\/h5>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; height: 428px; width: 940.6px;\" colspan=\"4\">\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\n<ul>\n<li>Review the advantages and disadvantages of IV medications (Table 7.7)<\/li>\n<li>Be able to answer the preparation questions for intravenous medication in Table 7.9 before administering the medication.<\/li>\n<li>If the medication has been diluted and there is wastage, always discard unused diluted portion of the prepared IV medication before going to the bedside.<\/li>\n<li>Always follow agency policies and guidelines when preparing and administering medications<\/li>\n<li>Always label the syringe with 2 patient identifiers, date, time, medication, concentration of the dose, dose, and your initials. Once the medication is prepared, never leave it unattended.<\/li>\n<li>NEVER administer an IV medication through an IV line that is infusing blood, blood products, heparin IV, insulin IV, cytotoxic medications, or parenteral nutrition solutions.<\/li>\n<li>Never administer an IV medication into an IV line that isn&#8217;t patent.<\/li>\n<li>Check compatibilities of the medication to with other medications \/ solutions in the same line<\/li>\n<li>Central venous catheters (midlines, percutaneous non-hemodialysis lines, PICC lines) may require special pre- and post-flushing procedures and specialized training.<\/li>\n<li>CVCs require at minimum a 10 ml syringe to decrease risk of catheter fracture.<\/li>\n<li>You will need a clock \/ timer\/ watch to time the rate of administration.<\/li>\n<li>Perform hand hygiene before preparing medications.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; text-align: center; height: 65px;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">Steps<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; text-align: center; height: 65px;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 511px;\" colspan=\"2\">1. Prepare one medication for one patient at the correct time as per agency policy. Review the physician&#8217;s order, PDTM, and MAR for the correct order and guidelines. Math calculations may be required to determine the correct dose to prepare the medication.<\/p>\n<p>&nbsp;<\/p>\n<p>Determine compatibilities of the medication to be given with the primary IV solution. If the primary solution contains medication that should not be stopped (e.g., heparin, morphine, pantoprazole, insulin, or blood or blood products),\u00a0\u00a0<strong>do not use this line. <\/strong>In this case establish another IV access.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 511px;\" colspan=\"2\">Always apply the SEVEN rights and THREE checks of medication administration.<\/p>\n<p>Review the agency policy if a medication is a stat, first-time, loading dose, or a one-time dose.<\/p>\n<p>Some agencies require high-alert medications to be double-checked by a second health care provider. Always follow agency policies.<\/p>\n<p>After preparing the medication, always label the medication syringe with two patient identifiers, date, time, medication, dose (e.g., morphine 2 mg), and your initials. Never leave the syringe unattended.<\/p>\n<p>If medications given simultaneously are incompatible, the mixing of these can create precipitates in the IV tubing which can initiate emboli formation in the blood.<\/p>\n<p>Stopping infusions that containing medications interrupts delivery of that medication.<\/p>\n<p>Blood and blood products are NOT compatible with ANY medication.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 16px;\" colspan=\"2\">2. Create privacy if possible.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 16px;\" colspan=\"2\">This provides comfort to patient.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 217px;\" colspan=\"2\">3. Confirm patient ID using two patient identifiers (e.g., name and date of birth) AND compare the MAR printout with the patient&#8217;s wristband to confirm patient ID.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 217px;\" colspan=\"2\">This ensures you have the correct patient and complies with agency standard for patient identification.<\/p>\n<figure id=\"attachment_6460\" aria-describedby=\"caption-attachment-6460\" style=\"width: 202px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-029.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6460\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/06\/Sept-22-2015-029-300x163.jpg\" alt=\"Identify patient with two identifiers\" width=\"202\" height=\"110\" \/><\/a><figcaption id=\"caption-attachment-6460\" class=\"wp-caption-text\">Compare MAR to patient wristband<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 34px;\" colspan=\"2\">4. Check allergy band for any allergies, and ask patient about type and severity of reaction.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 34px;\" colspan=\"2\">This ensures allergy status is correct on the MAR and on patient allergy band.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 88px;\" colspan=\"2\">5. Discuss purpose, action, and possible side effects of the medication. Provide patient an opportunity to ask questions. Encourage patient to report discomfort at the IV site (pain, swelling, or burning).<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 88px;\" colspan=\"2\">Keeping patient informed of what is being administered helps decrease anxiety.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 56px;\" colspan=\"2\">6. <a href=\"http:\/\/opentextbc.ca\/clinicalskills\/chapter\/1-6-hand-hygiene\/\">Perform hand hygiene<\/a><\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 56px;\" colspan=\"2\">Prevents the transmission of microorganisms.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 14px;\" colspan=\"2\">7. Assess IV insertion site. See <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-5-iv-administration-equipment\/\">Checklist 65<\/a>.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 14px;\" colspan=\"2\">Redness, swelling and leaking suggest complications.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 316px;\" colspan=\"2\">8. Select IV access port closest to the patient. Clean access port using friction with an alcohol swab for 15 seconds. Allow to dry.<\/p>\n<figure id=\"attachment_885\" aria-describedby=\"caption-attachment-885\" style=\"width: 162px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-022.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-885\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-300x279.jpg\" alt=\"Clean port with an alcohol swab\" width=\"162\" height=\"150\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-300x279.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-768x714.jpg 768w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-65x60.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-225x209.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-350x325.jpg 350w\" sizes=\"auto, (max-width: 162px) 100vw, 162px\" \/><\/a><figcaption id=\"caption-attachment-885\" class=\"wp-caption-text\">Clean port with an alcohol swab<\/figcaption><\/figure>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 316px;\" colspan=\"2\">The closest port allows the medication to reach the blood stream quickly.<\/p>\n<p>Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection. Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective.<\/p>\n<p>Refer to agency guidelines for VAD <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\">flushing &amp; locking protocols.<\/a><\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 104px;\" colspan=\"2\">9. Stop the infusion.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 104px;\" colspan=\"2\">Stopping the infusion for an IV run by gravity involves clamping a slide clamp distal to the access port or rolling the roller clamp to the closed position OR folding the tubing on itself and pinching it.<\/p>\n<p>&nbsp;<\/p>\n<p>Stopping the infusion for an IV run by an EID \/ pump simply involves stopping the machine.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 256px;\" colspan=\"2\">10. Verify site patency.<\/p>\n<p>&nbsp;<\/p>\n<p>Luer lock a 10 ml saline filled syringe to the access port closest to the patient.<\/p>\n<p>Aspirate and assess for blood flashback in the line. Forward flush 10 ml normal saline syringe using turbulent technique. THIS IS THE FLUSH PRIOR.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/DSC_0926.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6186 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/DSC_0926-300x199.jpg\" alt=\"Flushing extension tubing with NS at the same rate\" width=\"262\" height=\"174\" \/><\/a><\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 256px;\" colspan=\"2\">\u00a0<strong>Checking patency of PVAD short<\/strong>: you can aspirate&#8230; or not. Likely you can assess patency through observation of the site with an infusing IV. PVAD short sites that are not patent may be edematous (suggests infiltration), may not be infusing (observe for drops in the drip chamber) or the EIDs \/ IV pumps alerts presence of an occlusion.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Checking patency of midline, CVC (PICC \/ non-hemodialysis line)<\/strong>: aspirate for blood return. When blood flashback present in tubing, forward flush using turbulent technique. If there is no blood return, trouble shoot according to agency protocol and \/ or contact the IV team \/ PICC nurse for further assessment.<\/p>\n<p>Using a needleless system prevents needle-stick injuries.<\/p>\n<p>New recommendations include flushing before AND after medication administration.<\/p>\n<p>10 ml syringes decrease risk of catheter fracture. Flushing the line clears aspirated\u00a0 blood and reduces risk of clotting and occlusion. Turbulent flush cleans IV lumen of medication residue and fibrin. DO NOT force if resistance is felt.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 263px;\" colspan=\"2\">11.\u00a0Remove syringe.<\/p>\n<p>&nbsp;<\/p>\n<p>Clean IV access port for 15 seconds with alcohol and friction. Allow to dry.<\/p>\n<p>&nbsp;<\/p>\n<p>Luer lock medication syringe to the access port.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 263px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.<\/p>\n<p><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-028.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-888 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028-300x254.jpg\" alt=\"Inject IV medication slowly\" width=\"184\" height=\"155\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028-300x254.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028-768x650.jpg 768w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028-65x55.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028-225x190.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-028-350x296.jpg 350w\" sizes=\"auto, (max-width: 184px) 100vw, 184px\" \/><\/a><\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 157px;\" colspan=\"2\">12. \u00a0Inject medication at the recommended rate according to PDTM. Use a timer \/ watch \/ clock to monitor time.\u00a0Administer the medication slow and steady. Attempt to have half of the syringe emptied in half of the recommended infusion time.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 157px;\" colspan=\"2\">Timing of the administration promotes safer medication delivery. Rapid injection of IV medications can have serious consequences for the patient<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 16px;\" colspan=\"2\">13.\u00a0Remove empty medication syringe.<\/p>\n<p>&nbsp;<\/p>\n<p>Clean port using alcohol and friction.<\/p>\n<p>&nbsp;<\/p>\n<p>Luer lock a 10 ml saline filled syringe to the access port.<\/p>\n<p>&nbsp;<\/p>\n<p>Flush with volume directed by agency flushing protocol at the SAME rate as the medication delivery, according to guidelines found in the PDTM. (See <a href=\"#IVClearing\">Rationale for Flushing with NS after Administering an IV Medication<\/a>.) THIS IS THE FLUSH AFTER.<\/p>\n<p>&nbsp;<\/p>\n<p>Resume the infusion.<\/p>\n<p>&nbsp;<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 16px;\" colspan=\"2\">\n<figure id=\"attachment_889\" aria-describedby=\"caption-attachment-889\" style=\"width: 173px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-029.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-889\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029-300x259.jpg\" alt=\"Remove medication syringe\" width=\"173\" height=\"149\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029-300x259.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029-768x664.jpg 768w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029-65x56.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029-225x194.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-029-350x302.jpg 350w\" sizes=\"auto, (max-width: 173px) 100vw, 173px\" \/><\/a><figcaption id=\"caption-attachment-889\" class=\"wp-caption-text\">Remove medication syringe<\/figcaption><\/figure>\n<p><span style=\"font-family: inherit; font-size: inherit;\">\u00a0Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective. Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.<\/span><\/p>\n<div class=\"mceTemp\">\n<p>The final flush does NOT have to ensure positive pressure is achieved because the infusion will be resumed.<\/p>\n<\/div>\n<p>Always assess IV sites before and after administration of IV medications.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 52px;\" colspan=\"2\">14. Dispose of all syringes, and blunt fills and blunt fill filters as per agency protocol.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 52px;\" colspan=\"2\">Blunt fill and blunt fill filters are disposed of in sharps containers to\u00a0prevent accidental needle-stick injury.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 60px;\" colspan=\"2\">15.\u00a0<a href=\"http:\/\/opentextbc.ca\/clinicalskills\/chapter\/1-6-hand-hygiene\/\">Perform hand hygiene<\/a>.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 60px;\" colspan=\"2\">This reduces transmission of microorganisms.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 34px;\" colspan=\"2\">16. Document as per agency protocol.<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 34px;\" colspan=\"2\">Document time, reason, drug, dose, therapeutic effect, and any adverse reactions.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 456.6px; height: 52px;\" colspan=\"2\">17. Evaluate the patient for therapeutic effect and adverse reactions according to appropriate time frame (onset and peak of medication).<\/td>\n<td style=\"border: 1px solid #000000; width: 467px; height: 52px;\" colspan=\"2\">Observations provide additional safety measures, especially for high-alert medications. IV medications act rapidly.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 940.6px; height: 34px;\" colspan=\"4\">Data source: Berman &amp; Snyder, 2016; Canadian Institute for Health Information, 2009; Clayton et al., 2010; Perry et al., 2018;\u00a0Workers Compensation Act, 2015<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<div class=\"textbox shaded\">Watch the video: <em><a href=\"https:\/\/barabus.tru.ca\/nursing\/administering_med_iv_infusion.html\">Administering Medications: Direct IV &#8211;\u00a0Into an IV with an Infusion<\/a>\u00a0<\/em> \u00a0<span style=\"color: #333333;\">by Ren\u00e9e Anderson &amp; Wendy McKenzie Thompson Rivers University<\/span><\/div>\n<p>Checklist 62 reviews the steps to administer an IV medication through an existing IV line with incompatible IV solution.\u00a0Review the preparation questions for intravenous medication in <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/7-6-intravenous-medications-by-direct-iv-formerly-iv-push\/\">Table 7.8<\/a> prior to the medication administration.<\/p>\n<p>\u200b<\/p>\n<table style=\"border-color: #000000; height: 2684px;\">\n<tbody>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; text-align: center; height: 191px; width: 978.2px;\" colspan=\"4\">\n<h3 style=\"text-align: center;\"><a id=\"checklist62\"><\/a><a id=\"checklist62\"><\/a>Checklist 62: Administering Medications IV Direct into an Infusing IV with <strong>Incompatible<\/strong> IV Solution\u00a0(PVAD Short, Midline, PICC, Percutaneous Non-Hemodialysis CVC)<\/h3>\n<h5 style=\"text-align: center;\"><em><span style=\"color: #000000;\">Disclaimer:\u00a0Always review and follow your agency policy regarding this specific skill.<\/span><\/em><\/h5>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; height: 480px; width: 978.2px;\" colspan=\"4\">\n<h5><span style=\"color: #333333;\">Safety considerations:\u00a0<\/span><\/h5>\n<ul>\n<li>Review the advantages and disadvantages of IV medications (Table 7.8).<\/li>\n<li>Be able to answer the preparation questions for intravenous medication in Table 7.8 before administering the medication.<\/li>\n<li>If the medication has been diluted and there is wastage, always discard unused diluted portion of the prepared IV medication before going to the bedside.<\/li>\n<li>Always follow agency policies and guidelines when preparing and administering medications.<\/li>\n<li>Always label the syringe with 2 patient identifiers, date, time, medication, concentration of the dose, dose, and your initials. Once the medication is prepared, never leave it unattended.<\/li>\n<li>NEVER administer an IV medication through an IV line that is infusing blood, blood products, heparin IV, insulin IV, cytotoxic medications, or parenteral nutrition solutions.<\/li>\n<li>Never administer an IV medication into an IV line that isn&#8217;t patent.<\/li>\n<li>Check compatibilities of the medication to the primary solution.<\/li>\n<li>Central venous catheters (midlines, percutaneous non-hemodialysis lines, PICC lines) may require special pre- and post-flushing procedures and specialized training.<\/li>\n<li>CVCs require at minimum a 10 ml syringe to decrease risk of catheter fracture.<\/li>\n<li>You will need a clock \/ watch\u00a0 timer to time the rate of administration.<\/li>\n<li>Perform hand hygiene before preparing medications.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; text-align: center; height: 65px;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">Steps<\/h4>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; text-align: center; height: 65px;\" colspan=\"2\">\n<h4 style=\"text-align: center;\">\u00a0Additional Information<\/h4>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 352px;\" colspan=\"2\">1. Prepare one medication for one patient at the correct time as per agency policy. Review the physician orders, PDTM, and MAR for the correct order and guidelines. Math calculations may be required to determine the correct dose to prepare the medication.<\/p>\n<p>Always check agency policy to ensure an IV solution or medication can be stopped temporarily (i.e., longer than it takes to check patency).\u00a0<span style=\"font-family: inherit; font-size: inherit;\">Some IV solutions (i.e., those with medications in the primary solution\u2014insulin, heparin) can not be stopped. If unable to temporarily stop an IV solution or IV medication, establish a new IV access at a different site.<\/span><\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 352px;\" colspan=\"2\">Always apply the SEVEN rights THREE checks of medication administration.<\/p>\n<p>Review the agency policy if a medication is a stat, first-time, loading dose, or a one-time dose.<\/p>\n<p>Some agencies require that high-alert medications be double-checked by a second health care provider. Always follow agency policies.<\/p>\n<p>After preparing the medication, always label the medication syringe with two patient identifiers, date, time, medication and dose (e.g., morphine 2 mg), dose, and your initials. Never leave the syringe unattended.<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 16px;\" colspan=\"2\">2. Create privacy if possible.<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 16px;\" colspan=\"2\">This provides comfort to patient.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 227px;\" colspan=\"2\">3. Confirm patient ID using two patient identifiers (e.g., name and date of birth) AND compare the MAR printout with the patient&#8217;s wristband to confirm patient ID.<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 227px;\" colspan=\"2\">This ensures you have the correct patient and complies with agency standard for patient identification.<\/p>\n<figure id=\"attachment_6460\" aria-describedby=\"caption-attachment-6460\" style=\"width: 221px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/09\/Sept-22-2015-029.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6460\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/06\/Sept-22-2015-029-300x163.jpg\" alt=\"Identify patient with two identifiers\" width=\"221\" height=\"120\" \/><\/a><figcaption id=\"caption-attachment-6460\" class=\"wp-caption-text\">Compare MAR to patient wristband<\/figcaption><\/figure>\n<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 34px;\" colspan=\"2\">4. Check allergy band for any allergies, and ask patient about type and severity of reaction.<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 34px;\" colspan=\"2\">This ensures allergy status is correct on the MAR and on patient allergy band.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 88px;\" colspan=\"2\">5. Discuss purpose, action, and possible side effects of the medication. Provide patient an opportunity to ask questions. Encourage patient to report discomfort at the IV site (pain, swelling, or burning).<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 88px;\" colspan=\"2\">Keeping patient informed of what is being administered helps decrease anxiety.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 34px;\" colspan=\"2\">6. Perform hand hygiene<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 34px;\" colspan=\"2\">Hand hygiene prevents the transmission of microorganisms.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 50px;\" colspan=\"2\">7. Assess IV insertion site. See <a style=\"font-family: inherit; font-size: inherit;\" href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-5-iv-administration-equipment\/\">Checklist 65\u00a0<\/a><\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 50px;\" colspan=\"2\">Redness, swelling and leaking suggest complications.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 291px;\" colspan=\"2\">8. Select IV access port closest to the patient. Clean access port using friction with an alcohol swab for 15 seconds. Allow to dry.<\/p>\n<figure id=\"attachment_885\" aria-describedby=\"caption-attachment-885\" style=\"width: 174px\" class=\"wp-caption aligncenter\"><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-022.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-885\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-300x279.jpg\" alt=\"Clean port with an alcohol swab\" width=\"174\" height=\"162\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-300x279.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-768x714.jpg 768w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-65x60.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-225x209.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-022-350x325.jpg 350w\" sizes=\"auto, (max-width: 174px) 100vw, 174px\" \/><\/a><figcaption id=\"caption-attachment-885\" class=\"wp-caption-text\">Clean port with an alcohol swab<\/figcaption><\/figure>\n<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 291px;\" colspan=\"2\">The closest port allows the medication to reach the blood stream quickly.<\/p>\n<p>&nbsp;<\/p>\n<p>Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection. Alcohol and friction sanitizes. Allowing alcohol to dry renders the antiseptic properties effective.<\/p>\n<p>&nbsp;<\/p>\n<p>Refer to agency guidelines for VAD <a href=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/chapter\/8-8-flushing-and-locking-pvad-short-cvad-picc-percutaneous-non-hemodialysis-lines\/\">flushing &amp; locking protocols.<\/a><\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 224px;\" colspan=\"2\">9. Stop the infusion.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 224px;\" colspan=\"2\">Stopping the infusion for an IV run by gravity involves clamping a slide clamp distal to the access port or rolling the roller clamp to the closed position OR fold the tubing on itself and pinch<\/p>\n<p>&nbsp;<\/p>\n<p>Stopping the infusion for an IV run by an EID \/ pump simply involves stopping the machine.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 276px;\" colspan=\"2\">10. Verify site patency<\/p>\n<p>&nbsp;<\/p>\n<p>Luer lock a 10 ml saline filled syringe to the access port closest to the patient. Aspirate and assess for blood flashback in the line. Forward flush 10 ml syringe using turbulent technique.<\/p>\n<p>&nbsp;<\/p>\n<p>THIS FLUSH WILL CLEAR THE LINE OF THE INCOMPATIBLE MEDICATION.<\/p>\n<p><a href=\"http:\/\/opentextbc.ca\/clinicalskills\/wp-content\/uploads\/sites\/82\/2015\/10\/Oct-2-2015-025.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-890 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025-300x244.jpg\" alt=\"Flush IV line with NS\" width=\"175\" height=\"142\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025-300x244.jpg 300w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025-768x626.jpg 768w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025-65x53.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025-225x183.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Oct-2-2015-025-350x285.jpg 350w\" sizes=\"auto, (max-width: 175px) 100vw, 175px\" \/><\/a><\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 276px;\" colspan=\"2\"><strong>Checking patency of PVAD short<\/strong>: you can aspirate&#8230; or not. Likely you can assess patency through observation of the site with an infusing IV.<\/p>\n<p>PVAD short sites that are not patent may be edematous (suggests infiltration) or not infusing (observe for drops in the drip chamber); or the IV pump\u00a0 indicates occlusion.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Checking patency of midline, <\/strong><strong>CVC<\/strong><strong> (PICC \/ non-hemodialysis line)<\/strong>: aspirate for blood return. When blood flashback is present in tubing, forward flush using turbulent technique. If there is no blood return, trouble shoot according to agency protocol and \/ or contact the IV team \/ PICC nurse for further assessment.<\/p>\n<p>&nbsp;<\/p>\n<p>Using a needleless system prevents needle-stick injuries.<\/p>\n<p>10 ml syringes decrease risk of catheter fracture. Flushing the line clears aspirated blood and reduces risk of clotting and occlusion and it clears the line of incompatible medication. Turbulent flush cleans IV lumen of medication residue and fibrin. DO NOT force if resistance is felt.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 113px;\" colspan=\"2\">11.\u00a0Remove syringe.<\/p>\n<p>&nbsp;<\/p>\n<p>Clean IV access port for 15 seconds with alcohol and friction.<\/p>\n<p>Allow to dry.<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 113px;\" colspan=\"2\">Cleaning access ports before each syringe is attached and after each syringe is detached reduces risk of infection.<\/p>\n<p>&nbsp;<\/p>\n<p>The IV line must remain clamped (shut off) to avoid accidental mixing of incompatible IV solution and the medication.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 10px;\" colspan=\"2\">12. Leur lock the medication syringe to the access port.<\/p>\n<p>Inject medication at the recommended rate according to PDTM. Use a timer \/ watch \/ clock to monitor time.\u00a0Administer the medication slow and steady. Attempt to have half of the syringe emptied in half of the recommended infusion time.<\/p>\n<p>&nbsp;<\/p>\n<p>Remove empty syringe. Clean port for 15 seconds using alcohol and friction.<\/p>\n<p>Attach a 10 ml normal saline syringe. Flush with volume directed by agency flushing protocol at the SAME rate as the medication delivery, according to guidelines found in the PDTM. (See <a href=\"#IVClearing#IVClearing\">Rationale for Flushing with NS after Administering an IV Medication<\/a>.) THIS FLUSH REMOVES MEDICATION FROM THE TUBING.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 10px;\" colspan=\"2\">This ensures safe medication administration at the correct rate. Rapid injection of IV medications can have serious consequences for the patient<\/p>\n<p>&nbsp;<\/p>\n<p>Always assess IV sites before and after administration of IV medications.<\/p>\n<p>&nbsp;<\/p>\n<p>This step delivers the medication that remains in the IV tubing at the same rate, and prevents patient from accidentally receiving a bolus of the medication. It also\u00a0clears the IV line to prevent any mixing of incompatible medication with the IV solution.<\/p>\n<p>The IV line must remain clamped to avoid accidental mixing of incompatible IV solution and the medication.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 10px;\" colspan=\"2\">13. Resume the IV infusion<\/p>\n<ul>\n<li>Gravity infusion:\u00a0Unclamp IV line and regulate the rate using the roller clamp.<\/li>\n<li>EID \/ pump infusion: Restart IV infusion device.<\/li>\n<\/ul>\n<p>Assess the IV site.<\/p>\n<p>&nbsp;<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 10px;\" colspan=\"2\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-4877 alignleft\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2019\/09\/Baxter_Colleague_CX_infusion_pump-225x300.jpg\" alt=\"\" width=\"120\" height=\"160\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2019\/09\/Baxter_Colleague_CX_infusion_pump-225x301.jpg 225w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2019\/09\/Baxter_Colleague_CX_infusion_pump-65x87.jpg 65w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2019\/09\/Baxter_Colleague_CX_infusion_pump.jpg 262w\" sizes=\"auto, (max-width: 120px) 100vw, 120px\" \/><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-891 aligncenter\" src=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Sept-22-2015-086-199x300-199x300.jpg\" alt=\"\" width=\"118\" height=\"177\" srcset=\"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Sept-22-2015-086-199x300.jpg 199w, https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-content\/uploads\/sites\/472\/2015\/05\/Sept-22-2015-086-199x300-65x98.jpg 65w\" sizes=\"auto, (max-width: 118px) 100vw, 118px\" \/><\/p>\n<p><span style=\"font-size: 1.125rem; font-family: inherit;\">Resume the IV infusion\u00a0<\/span><\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 155px;\" colspan=\"2\">14.\u00a0Dispose of all syringes and blunt fills and blunt fill filters as per agency protocol.<\/p>\n<p>&nbsp;<\/p>\n<p>Perform hand hygiene.<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 155px;\" colspan=\"2\">Blunt fill and blunt fill filters are disposed of in sharps containers to\u00a0prevent accidental needle-stick injury.<\/p>\n<p>&nbsp;<\/p>\n<p>This reduces the transmission of microorganisms.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 462.417px; height: 52px;\" colspan=\"2\">15. Evaluate the patient&#8217;s response to the medication in the appropriate time frame.<\/p>\n<p>Document according to agency protocol<\/td>\n<td style=\"border: 1px solid #000000; width: 498.783px; height: 52px;\" colspan=\"2\">Observe patient for expected therapeutic effects and adverse reactions.<\/p>\n<p>Observations provide additional safety measures, especially for high-alert medications. IV medications act rapidly.<\/td>\n<\/tr>\n<tr style=\"border-color: #000000;\">\n<td style=\"border: 1px solid #000000; width: 978.2px; height: 16px;\" colspan=\"4\">Data source: Berman &amp; Snyder, 2016; Canadian Institute for Health Information, 2009; Clayton et al., 2010; Perry et al., 2014<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div><\/div>\n<div class=\"bcc-box bcc-info\">\n<h3 style=\"text-align: center;\">Critical Thinking Exercises<\/h3>\n<ol>\n<li>Find a resource that will advise you about onset, peak, and duration of morphine IV.<\/li>\n<li>What information should be on the label of an IV medication syringe after it is prepared?<\/li>\n<\/ol>\n<h1>Attributions<\/h1>\n<p>Figure 7.20 Cleaning access port by author is\u00a0licensed under a\u00a0<a href=\"http:\/\/creativecommons.org\/licenses\/by\/4.0\/\">Creative Commons Attribution 4.0 International License<\/a>.<\/p>\n<p>Figure 7.30 Leur lock syringe to needleless cap by author\u00a0is licensed under a\u00a0<a href=\"http:\/\/creativecommons.org\/licenses\/by\/4.0\/\">Creative Commons Attribution 4.0 International License<\/a>.<\/p>\n<p>Figure 7.31 Apply slide clamp by author\u00a0is licensed under a\u00a0<a href=\"http:\/\/creativecommons.org\/licenses\/by\/4.0\/\">Creative Commons Attribution 4.0 International License<\/a>.<\/p>\n<p>Figure 7.32 <a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:%CE%9F%CE%B3%CE%BA%CE%BF%CE%BC%CE%B5%CF%84%CF%81%CE%B9%CE%BA%CE%AE_%CE%B1%CE%BD%CF%84%CE%BB%CE%AF%CE%B1_%CF%87%CE%BF%CF%81%CE%AE%CE%B3%CE%B7%CF%83%CE%B7%CF%82_%CF%85%CE%B3%CF%81%CF%8E%CE%BD.png\">Volumetric infusion pump<\/a> by <a href=\"https:\/\/commons.wikimedia.org\/w\/index.php?title=%CE%A3%CF%84%CE%AD%CE%BB%CE%B9%CE%BF%CF%82_%CE%A0%CE%B1%CF%81%CE%B9%CF%83%CF%83%CF%8C%CF%80%CE%BF%CF%85%CE%BB%CE%BF%CF%82,_%CE%95%CE%A0_%CE%A4%CE%95%CE%99_%CE%91%CE%B8%CE%AE%CE%BD%CE%B1%CF%82&amp;action=edit&amp;redlink=1\"><br \/>\n\u03a3\u03c4\u03ad\u03bb\u03b9\u03bf\u03c2 \u03a0\u03b1\u03c1\u03b9\u03c3\u03c3\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2, \u0395\u03a0 \u03a4\u0395\u0399 \u0391\u03b8\u03ae\u03bd\u03b1\u03c2<\/a> is licensed under a\u00a0<a href=\"https:\/\/en.wikipedia.org\/wiki\/en:Creative_Commons\">Creative Commons<\/a>\u00a0<a href=\"https:\/\/creativecommons.org\/licenses\/by-sa\/3.0\/deed.en\">Attribution-Share Alike\u00a0<\/a>3.0 license<\/p>\n<\/div>\n","protected":false},"author":397,"menu_order":6,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":"cc-by"},"chapter-type":[],"contributor":[],"license":[50],"class_list":["post-892","chapter","type-chapter","status-publish","hentry","license-cc-by"],"part":809,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/pressbooks\/v2\/chapters\/892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/wp\/v2\/users\/397"}],"version-history":[{"count":27,"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/pressbooks\/v2\/chapters\/892\/revisions"}],"predecessor-version":[{"id":5217,"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/pressbooks\/v2\/chapters\/892\/revisions\/5217"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/pressbooks\/v2\/parts\/809"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/pressbooks\/v2\/chapters\/892\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/wp\/v2\/media?parent=892"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/pressbooks\/v2\/chapter-type?post=892"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/wp\/v2\/contributor?post=892"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/clinicalproceduresforsaferpatientcaretrubscn\/wp-json\/wp\/v2\/license?post=892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}